1576 lines
491 KiB
HTML
1576 lines
491 KiB
HTML
|
<!DOCTYPE html>
|
|||
|
|
<html xmlns="http://www.w3.org/1999/xhtml">
|
|||
|
|
<head>
|
|||
|
|
<meta charset="utf-8" />
|
|||
|
|
<script type="text/javascript" src="https://bam-cell.nr-data.net/1/44925d6b58?a=390221574&v=1216.487a282&to=NFBaMhZVDRIHABUPCg0aeQUQXQwPSScTExUCWWQIC1AGPSUMDxIXDFlUAxZoLQ4CBjcPABR2VwgQRgwNCgYTS1sVXF0R&rst=8269&ck=1&ref=https://www.fiercepharma.com/marketing/novavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&ap=1378&be=218&fe=8164&dc=503&perf=%7B%22timing%22:%7B%22of%22:1651697741863,%22n%22:0,%22f%22:0,%22dn%22:32,%22dne%22:77,%22c%22:77,%22s%22:88,%22ce%22:124,%22rq%22:125,%22rp%22:169,%22rpe%22:211,%22dl%22:173,%22di%22:503,%22ds%22:503,%22de%22:503,%22dc%22:8164,%22l%22:8164,%22le%22:8170%7D,%22navigation%22:%7B%7D%7D&fp=267&fcp=267&at=GBdZRF5PHhw%3D&jsonp=NREUM.setToken"></script>
|
|||
|
|
<script src="https://js-agent.newrelic.com/nr-1216.min.js"></script>
|
|||
|
|
<script type="text/javascript" async="async" src="https://static.criteo.net/js/ld/publishertag.prebid.117.js"></script>
|
|||
|
|
<script type="text/javascript" async="async" src="https://www.google-analytics.com/plugins/ua/ec.js"></script>
|
|||
|
|
<script type="text/javascript" async="async" src="https://www.google-analytics.com/plugins/ua/ecommerce.js"></script>
|
|||
|
|
<script defer="defer" src="https://p.ad.gt/api/v1/p/170?au_id=AU1D-0100-001651697744-CIIGXHMK-F4XV"></script>
|
|||
|
|
<script async="async" src="https://id.halo.ad.gt/api/v1/partner/170?sync=1&url=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid"></script>
|
|||
|
|
<script src="https://connect.facebook.net/signals/config/2360281497619504?v=2.9.58&r=stable" async="async"></script>
|
|||
|
|
<script async="async" src="//connect.facebook.net/en_US/fbevents.js"></script>
|
|||
|
|
<script src="https://script.crazyegg.com/pages/versioned/common-scripts/11.1.420.js" type="text/javascript" async="async"></script>
|
|||
|
|
<script type="text/javascript" async="async" src="https://ml314.com/tag.aspx?442022"></script>
|
|||
|
|
<script async="async" id="olyticsImport" type="text/javascript" data-oid="5d6cdb41c83d4fb0a6a384e42aa46df6" src="https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js"></script>
|
|||
|
|
<script type="text/javascript" async="async" src="https://ws.zoominfo.com/pixel/WgRbL7NLS90BFPSb6pBa"></script>
|
|||
|
|
<script type="text/javascript" async="async" src="https://s.adroll.com/j/roundtrip.js"></script>
|
|||
|
|
<script type="text/javascript" async="async" src="https://cdn.parsely.com/keys/fiercepharma.com/p.js"></script>
|
|||
|
|
<script type="text/javascript" async="async" src="https://script.crazyegg.com/pages/scripts/0092/4740.js"></script>
|
|||
|
|
<script type="text/javascript" async="async" src="https://www.google-analytics.com/analytics.js"></script>
|
|||
|
|
<script src="https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ" async="async"></script>
|
|||
|
|
<script>
|
|||
|
|
<![CDATA[
|
|||
|
|
window.mobileCheck=function(){var check=false;(function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4)))check=true;})(navigator.userAgent||navigator.vendor||window.opera);return check;};window.dataLayerValues=window.dataLayerValues||{};window.dataLayerValues.isMobileQuery=window.mobileCheck();window.dataLayer=window.dataLayer||[];window.dataLayer.push(window.dataLayerValues);window.loadExternal=true;let disableFor=['bot','lighthouse','google','python-requests'];disableFor.forEach(function(elem){if(window.navigator.userAgent.toLowerCase().includes(elem)===true){window.loadExternal=false;}});
|
|||
|
|
]]>
|
|||
|
|
</script>
|
|||
|
|
<link rel="canonical" href="https://www.fiercepharma.com/marketing/novavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid" />
|
|||
|
|
<meta name="news_keywords" content="Novavax, COVID-19, Pfizer, Moderna, Johnson & Johnson, AstraZeneca, BioNTech, Comirnaty, Evusheld, Spikevax, FDA advisory committee, patient education, awareness campaigns,Pharma, Marketing, Fierce Pharma Homepage,Marketing" />
|
|||
|
|
<meta name="description" content="Pfizer, Moderna and Johnson & Johnson were quickest off the mark in getting COVID vaccines into American arms, but Novavax is hoping to add another pandemic vaccine to the U.S." />
|
|||
|
|
<meta name="keywords" content="Novavax, COVID-19, Pfizer, Moderna, Johnson & Johnson, AstraZeneca, BioNTech, Comirnaty, Evusheld, Spikevax, FDA advisory committee, patient education, awareness campaigns,Pharma, Marketing, Fierce Pharma Homepage,Marketing" />
|
|||
|
|
<meta name="gtm-article" content="1296731" />
|
|||
|
|
<meta name="gtm-contenttype" content="Article" />
|
|||
|
|
<meta name="gtm-keywords" content="Novavax, COVID-19, Pfizer, Moderna, Johnson & Johnson, AstraZeneca, BioNTech, Comirnaty, Evusheld, Spikevax, FDA advisory committee, patient education, awareness campaigns" />
|
|||
|
|
<meta name="gtm-section" content="Marketing" />
|
|||
|
|
<meta name="twitter:image" content="https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<meta name="og:image" content="https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<meta name="image:content-well" content="https://qtxasset.com/cdn-cgi/image/w=280,h=210,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<meta name="parsely-image-url" content="https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<meta property="og:site_name" content="Fierce Pharma" />
|
|||
|
|
<meta property="og:type" content="article" />
|
|||
|
|
<meta property="og:url" content="https://www.fiercepharma.com/marketing/novavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid" />
|
|||
|
|
<meta property="og:title" content="Novavax, eyeing the COVID 'vaccine hesitant' and kids, unveils new education campaigns as Nuvaxovid nears US finish line" />
|
|||
|
|
<meta property="og:description" content="Pfizer, Moderna and Johnson & Johnson were quickest off the mark in getting COVID vaccines into American arms, but Novavax is hoping to add another pandemic vaccine to the U.S. | Pfizer, Moderna and Johnson & Johnson were quickest off the mark in getting COVID vaccines into American arms, but Novavax is hoping to add another pandemic vaccine to the U.S. mix soon—and it's pushing new campaigns to get the word out." />
|
|||
|
|
<meta property="og:image" content="https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<meta property="og:image:url" content="https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<meta property="og:image:secure_url" content="https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<meta property="og:image:alt" content="Novavax" />
|
|||
|
|
<meta property="article:author" content="Ben Adams" />
|
|||
|
|
<meta property="article:section" content="Pharma, Marketing, Fierce Pharma Homepage" />
|
|||
|
|
<meta property="article:tag" content="Novavax" />
|
|||
|
|
<meta property="article:tag" content="COVID-19" />
|
|||
|
|
<meta property="article:tag" content="Pfizer" />
|
|||
|
|
<meta property="article:tag" content="Moderna" />
|
|||
|
|
<meta property="article:tag" content="Johnson & Johnson" />
|
|||
|
|
<meta property="article:tag" content="AstraZeneca" />
|
|||
|
|
<meta property="article:tag" content="BioNTech" />
|
|||
|
|
<meta property="article:tag" content="Comirnaty" />
|
|||
|
|
<meta property="article:tag" content="Evusheld" />
|
|||
|
|
<meta property="article:tag" content="Spikevax" />
|
|||
|
|
<meta property="article:tag" content="FDA advisory committee" />
|
|||
|
|
<meta property="article:tag" content="patient education" />
|
|||
|
|
<meta property="article:tag" content="awareness campaigns" />
|
|||
|
|
<meta property="article:tag" content="Pharma" />
|
|||
|
|
<meta property="article:tag" content="Marketing" />
|
|||
|
|
<meta property="article:tag" content="Fierce Pharma Homepage" />
|
|||
|
|
<meta property="article:tag" content="Marketing" />
|
|||
|
|
<meta property="article:published_time" content="2022-03-10T08:30:00-0500" />
|
|||
|
|
<meta name="parsely-author" content="Ben Adams" />
|
|||
|
|
<meta name="parsely-image-url" content="https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<meta name="parsely-link" content="https://www.fiercepharma.com/marketing/novavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid" />
|
|||
|
|
<meta name="parsely-pub-date" content="Thu, 03/10/2022 - 08:30" />
|
|||
|
|
<meta name="parsely-section" content="Marketing" />
|
|||
|
|
<meta name="parsely-tags" content="Novavax, COVID-19, Pfizer, Moderna, Johnson & Johnson, AstraZeneca, BioNTech, Comirnaty, Evusheld, Spikevax, FDA advisory committee, patient education, awareness campaigns,Pharma, Marketing, Fierce Pharma Homepage,Marketing" />
|
|||
|
|
<meta name="parsely-title" content="Novavax, eyeing the COVID 'vaccine hesitant' and kids, unveils new education campaigns as Nuvaxovid nears US finish line" />
|
|||
|
|
<meta name="parsely-type" content="post" />
|
|||
|
|
<meta name="twitter:card" content="summary_large_image" />
|
|||
|
|
<meta name="twitter:description" content="Pfizer, Moderna and Johnson & Johnson were quickest off the mark in getting COVID vaccines into American arms, but Novavax is hoping to add another pandemic vaccine to the U.S. | Pfizer, Moderna and Johnson & Johnson were quickest off the mark in getting COVID vaccines into American arms, but Novavax is hoping to add another pandemic vaccine to the U.S. mix soon—and it's pushing new campaigns to get the word out." />
|
|||
|
|
<meta name="twitter:title" content="Novavax, eyeing the COVID 'vaccine hesitant' and kids, unveils new education campaigns as Nuvaxovid nears US finish line" />
|
|||
|
|
<meta name="twitter:url" content="https://www.fiercepharma.com/marketing/novavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid" />
|
|||
|
|
<meta name="twitter:image:alt" content="Novavax" />
|
|||
|
|
<meta name="twitter:image" content="https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<script type="text/javascript">
|
|||
|
|
//<![CDATA[
|
|||
|
|
if (window.loadExternal) {!(function () { window.googletag = window.googletag || {}; window.vmpbjs = window.vmpbjs || {}; window.vpb = window.vpb || {}; vpb.fastLoad = true; googletag.cmd = googletag.cmd || []; vmpbjs.cmd = vmpbjs.cmd || []; var cmds = googletag.cmd.slice(0) || []; googletag.cmd.length=0; var ready = false; function exec(cb) { return cb.call(googletag); } googletag.cmd.push(function () { googletag.cmd.unshift = function (cb) { if (ready) { return exec(cb); } cmds.unshift(cb); if (cb._startgpt) { ready = true; cmds.forEach(cb=> { exec(cb); }); } }; googletag.cmd.push = function (cb) { if (ready) { return exec(cb); } cmds.push(cb); }; }); googletag.cmd.push = function (cb) { cmds.push(cb) }; googletag.cmd.unshift = function (cb) { cmds.unshift(cb); if (cb._startgpt) { ready = true; if (googletag.apiReady) { cmds.forEach(function (cb) { googletag.cmd.push(cb); }) } else { googletag.cmd = cmds; } } }; var dayMs = 36e5, cb = parseInt(Date.now() / dayMs), vpbSrc = '//player.mediafuse.com/prebidlink/' + cb + '/wrapper_hb_302826_6936.js', pbSrc = vpbSrc.replace('wrapper_hb', 'hb'), gptSrc = '//securepubads.g.doubleclick.net/tag/js/gpt.js', c = document.head || document.body || document.documentElement; function loadScript(src, cb) { var s = document.createElement('script'); s.src = src; s.defer=false; c.appendChild(s); s.onload = cb; s.onerror = function(){ var fn = function(){}; fn._startgpt = true; googletag.cmd.unshift(fn); }; return s; } loadScript(pbSrc); loadScript(gptSrc); loadScript(vpbSrc); })()}
|
|||
|
|
//]]>
|
|||
|
|
</script>
|
|||
|
|
<script src="//player.mediafuse.com/prebidlink/458804/hb_302826_6936.js"></script>
|
|||
|
|
<script src="//securepubads.g.doubleclick.net/tag/js/gpt.js"></script>
|
|||
|
|
<script src="//player.mediafuse.com/prebidlink/458804/wrapper_hb_302826_6936.js"></script>
|
|||
|
|
<meta name="Generator" content="Drupal 9 (https://www.drupal.org)" />
|
|||
|
|
<meta name="MobileOptimized" content="width" />
|
|||
|
|
<meta name="HandheldFriendly" content="true" />
|
|||
|
|
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
|
|||
|
|
<link rel="prefetch" href="/modules/custom/quartz_apifirst/compiled/runtime.js?v=98c7521aa7bcb40e" />
|
|||
|
|
<link rel="prefetch" href="/modules/custom/quartz_apifirst/compiled/vendor-runtime-core.esm-bundler.js?v=98c7521aa7bcb40e" />
|
|||
|
|
<link rel="prefetch" href="/modules/custom/quartz_apifirst/compiled/vendor-compiler-core.esm-bundler.js?v=98c7521aa7bcb40e" />
|
|||
|
|
<link rel="prefetch" href="/modules/custom/quartz_apifirst/compiled/vendor-runtime-dom.esm-bundler.js?v=98c7521aa7bcb40e" />
|
|||
|
|
<link rel="prefetch" href="/jsonapi/node/article/ec02b4b7-6893-47f9-8a7d-8ef55f3a9fca" />
|
|||
|
|
<link rel="prefetch" href="/jsonapi/node/article/f95094da-693d-4fd6-ad1c-44c78ebb1444" />
|
|||
|
|
<link rel="prefetch" href="/jsonapi/node/article/978daefc-c789-4ef0-9061-6f80b47f9e05" />
|
|||
|
|
<link rel="prefetch" href="/jsonapi/node/article/2d6e1ea2-0622-46c0-9abb-974b1cf53dd9" />
|
|||
|
|
<link rel="prefetch" href="/jsonapi/node/article/188cd6df-5450-4858-b9d5-d3fa1e625a9d" />
|
|||
|
|
<link rel="prefetch" href="/jsonapi/node/article/41633703-5351-4e84-ba60-0a260da5f531" />
|
|||
|
|
<link rel="prefetch" href="https://qtxasset.com/cdn-cgi/image/w=705,h=398,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" />
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
@charset "UTF-8";/*!
|
|||
|
|
* Bootstrap v4.6.1 (https://getbootstrap.com/)
|
|||
|
|
* Copyright 2011-2021 The Bootstrap Authors
|
|||
|
|
* Copyright 2011-2021 Twitter, Inc.
|
|||
|
|
* Licensed under MIT (https://github.com/twbs/bootstrap/blob/main/LICENSE)
|
|||
|
|
*/:root{--blue:#007bff;--indigo:#6610f2;--purple:#6f42c1;--pink:#e83e8c;--red:#dc3545;--orange:#fd7e14;--yellow:#ffc107;--green:#28a745;--teal:#20c997;--cyan:#17a2b8;--white:#fff;--gray:#6c757d;--gray-dark:#343a40;--primary:#0079c0;--secondary:#ff4e2e;--success:#28a745;--info:#17a2b8;--warning:#ffc107;--danger:#dc3545;--light:#f8f9fa;--dark:#343a40;--breakpoint-xs:0;--breakpoint-sm:576px;--breakpoint-md:768px;--breakpoint-lg:992px;--breakpoint-xl:1320px;--font-family-sans-serif:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,"Helvetica Neue",Arial,"Noto Sans","Liberation Sans",sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol","Noto Color Emoji";--font-family-monospace:SFMono-Regular,Menlo,Monaco,Consolas,"Liberation Mono","Courier New",monospace}*,::after,::before{box-sizing:border-box}html{font-family:sans-serif;line-height:1.15;-webkit-text-size-adjust:100%;-webkit-tap-highlight-color:transparent}article,aside,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}body{margin:0;font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,"Helvetica Neue",Arial,"Noto Sans","Liberation Sans",sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol","Noto Color Emoji";font-size:1rem;font-weight:400;line-height:1.5;color:#343a40;text-align:left;background-color:#fff}[tabindex="-1"]:focus:not(:focus-visible){outline:0!important}hr{box-sizing:content-box;height:0;overflow:visible}h1,h2,h3,h4,h5,h6{margin-top:0;margin-bottom:.5rem}p{margin-top:0;margin-bottom:1rem}abbr[data-original-title],abbr[title]{text-decoration:underline;-webkit-text-decoration:underline dotted;text-decoration:underline dotted;cursor:help;border-bottom:0;-webkit-text-decoration-skip-ink:none;text-decoration-skip-ink:none}address{margin-bottom:1rem;font-style:normal;line-height:inherit}dl,ol,ul{margin-top:0;margin-bottom:1rem}ol ol,ol ul,ul ol,ul ul{margin-bottom:0}dt{font-weight:700}dd{margin-bottom:.5rem;margin-left:0}blockquote{margin:0 0 1rem}b,strong{font-weight:bolder}small{font-size:80%}sub,sup{position:relative;font-size:75%;line-height:0;vertical-align:baseline}sub{bottom:-.25em}sup{top:-.5em}a{color:var(--primary-color);text-decoration:none;background-color:transparent}a:hover{color:var(--secondary-color);text-decoration:underline}a:not([href]):not([class]){color:inherit;text-decoration:none}a:not([href]):not([class]):hover{color:inherit;text-decoration:none}code,kbd,pre,samp{font-family:SFMono-Regular,Menlo,Monaco,Consolas,"Liberation Mono","Courier New",monospace;font-size:1em}pre{margin-top:0;margin-bottom:1rem;overflow:auto;-ms-overflow-style:scrollbar}figure{margin:0 0 1rem}img{vertical-align:middle;border-style:none}svg{overflow:hidden;vertical-align:middle}table{border-collapse:collapse}caption{padding-top:.75rem;padding-bottom:.75rem;color:#6c757d;text-align:left;caption-side:bottom}th{text-align:inherit;text-align:-webkit-match-parent}label{display:inline-block;margin-bottom:.5rem}button{border-radius:0}button:focus:not(:focus-visible){outline:0}button,input,optgroup,select,textarea{margin:0;font-family:inherit;font-size:inherit;line-height:inherit}button,input{overflow:visible}button,select{text-transform:none}[role=button]{cursor:pointer}select{word-wrap:normal}[type=button],[type=reset],[type=submit],button{-webkit-appearance:button}[type=button]:not(:disabled),[type=reset]:not(:disabled),[type=submit]:not(:disabled),button:not(:disabled){cursor:pointer}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{padding:0;border-style:none}input[type=checkbox],input[type=radio]{box-sizing:border-box;padding:0}textarea{overflow:auto;resize:vertical}fieldset{min-width:0;padding:0;margin:0;border:0}legend{display:block;width:100%;max-width:100%;padding:0;margin-bottom:.5rem;font-size:1.5rem;line-height:inherit;color:inherit;white-space:normal}@media (max-width:1200px){legend{font-size:calc(1.275rem + .3vw)}}progress{vertical-align:baseline}[type=number]::-webkit-inner-spin-button,[type=number]::-webkit-outer-spin-button{heig
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<meta http-equiv="x-ua-compatible" content="ie=edge" />
|
|||
|
|
<script type="text/javascript">
|
|||
|
|
//<![CDATA[
|
|||
|
|
(window.NREUM||(NREUM={})).init={ajax:{deny_list:["bam-cell.nr-data.net"]}};(window.NREUM||(NREUM={})).loader_config={licenseKey:"44925d6b58",applicationID:"390221574"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var i=e[n]={exports:{}};t[n][0].call(i.exports,function(e){var i=t[n][1][e];return r(i||e)},i,i.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var i=0;i<n.length;i++)r(n[i]);return r}({1:[function(t,e,n){function r(){}function i(t,e,n,r){return function(){return s.recordSupportability("API/"+e+"/called"),o(t+e,[u.now()].concat(c(arguments)),n?null:this,r),n?void 0:this}}var o=t("handle"),a=t(9),c=t(10),f=t("ee").get("tracer"),u=t("loader"),s=t(4),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",v=l+"ixn-";a(p,function(t,e){d[e]=i(l,e,!0,"api")}),d.addPageAction=i(l,"addPageAction",!0),d.setCurrentRouteName=i(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,i="function"==typeof e;return o(v+"tracer",[u.now(),t,n],r),function(){if(f.emit((i?"":"no-")+"fn-start",[u.now(),r,i],n),i)try{return e.apply(this,arguments)}catch(t){throw f.emit("fn-err",[arguments,this,t],n),t}finally{f.emit("fn-end",[u.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=i(v,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),s.recordSupportability("API/noticeError/called"),o("err",[t,u.now(),!1,e])}},{}],2:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],3:[function(t,e,n){var r=!1;try{var i=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,i),window.removeEventListener("testPassive",null,i)}catch(o){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],4:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return o("storeMetric",n,null,"api"),n}function i(t,e){var n=[c,t,{name:t},e];return o("storeEventMetrics",n,null,"api"),n}var o=t("handle"),a="sm",c="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:c},recordSupportability:r,recordCustom:i}},{}],5:[function(t,e,n){function r(){return c.exists&&performance.now?Math.round(performance.now()):(o=Math.max((new Date).getTime(),o))-a}function i(){return o}var o=(new Date).getTime(),a=o,c=t(11);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=i},{}],6:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function i(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(u&&u<r.startTime)return;var i=[r],o=a({});o&&i.push(o),l("lcp",i)}}function o(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function c(t){if(t instanceof y&&!w){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=v.now()?n.fid=v.now()-e:e>v.offset&&e<=Date.now()?(e-=v.offset,n.fid=v.now()-e):e=v.now(),w=!0,l("timing",["fi",e,n])}}function f(t){"hidden"===t&&(u=v.now(),l("pageHide",[u]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var u,s,d,p,l=t("handle"),v=t("loader"),m=t(8),g=t(3),y=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}cat
|
|||
|
|
//]]>
|
|||
|
|
</script>
|
|||
|
|
<link rel="icon" href="https://qtxasset.com/quartz/qcloud5/fiercefavicon.ico" type="image/png" />
|
|||
|
|
<script src="/sites/qcloud5/files/google_tag/fiercepharma_com/google_tag.script.js?rba4b0" defer="defer"></script>
|
|||
|
|
<script>
|
|||
|
|
<![CDATA[
|
|||
|
|
class PageMeta{constructor(){let metaStore={};let metas=document.getElementsByTagName('meta');for(let i=0;i<metas.length;i++){if(typeof metas[i]!=='undefined'&&metas[i].getAttribute('name')){metaStore[metas[i].getAttribute('name')]=metas[i].getAttribute('content');}}
|
|||
|
|
this.metaVars=metaStore;}
|
|||
|
|
getMetaVars(){return this.metaVars;}
|
|||
|
|
getMetaValue(metaKeyName,defaultReturn=null){if(!this.metaVars.hasOwnProperty(metaKeyName)){return defaultReturn;}
|
|||
|
|
return this.metaVars[metaKeyName];}
|
|||
|
|
getFullGamInventoryPath(rootPath){let gtmSectionRoot=this.getMetaValue("gtm-section-root");if(gtmSectionRoot){rootPath+="/"+gtmSectionRoot.replace(/[^A-Z0-9]/ig,"").toLowerCase();}
|
|||
|
|
let gtmSection=this.getMetaValue("gtm-section");if(gtmSection){rootPath+="/"+gtmSection.replace(/[^A-Z0-9]/ig,"").toLowerCase();}
|
|||
|
|
return rootPath;}
|
|||
|
|
isArticle(){return!this.metaVars.hasOwnProperty('gtm-article')?false:parseInt(this.metaVars['gtm-article'])>0;}
|
|||
|
|
isSectionFront(){let isTaxonomy=this.getMetaValue('gtm-contenttype')==='taxonomy';if(isTaxonomy&&(this.getMetaValue('gtm-section')||this.getMetaValue('gtm-home'))){return 1;}
|
|||
|
|
return 0;}
|
|||
|
|
isBrowserLarger(pixels=1460){let width=Math.max(document.documentElement.clientWidth,window.innerWidth||0);return width>=parseInt(pixels);}}
|
|||
|
|
class PubAds{constructor(gamPath){this.enabled=true;this.gamPath=gamPath;let event=document.createEvent("CustomEvent");event.initCustomEvent('googletagEvent',false,false,{});this.googletagEvent=event;}
|
|||
|
|
getGamPath(){return this.gamPath;}
|
|||
|
|
barebonesDefine(gamPath,meta){googletag.pubads().setTargeting("section",meta.getMetaValue('gtm-section','0'));googletag.pubads().setTargeting("homefront",meta.getMetaValue('gtm-home',"0"));googletag.pubads().setTargeting("sectionfront",meta.getMetaValue('gtm-section-home',"0"));googletag.pubads().setTargeting("article",meta.isArticle()?"1":"0");googletag.pubads().setTargeting("nodeid",meta.getMetaValue('gtm-article',''));googletag.pubads().setTargeting("topic",meta.getMetaValue('gtm-topics',''));googletag.pubads().setTargeting("keyword",meta.getMetaValue('gtm-keywords',''));googletag.pubads().setTargeting("tag",meta.getMetaValue('keywords',''));googletag.pubads().setTargeting("path",window.location.pathname);googletag.pubads().setTargeting('browserLargerThan1460',meta.isBrowserLarger(1460)?"1":"0");let pubAds=this;googletag.cmd.push(function(){googletag.pubads().addEventListener('slotRequested',function(event){if(pubAds.dfpDebugOn()){console.group('[debug] Ad for slot ',event.slot.getSlotElementId(),' requested');console.groupEnd();}});});googletag.cmd.push(function(){googletag.pubads().addEventListener('slotOnload',function(event){if(pubAds.dfpDebugOn()){console.log('[debug]',"showAds","slotOnLoad","Slot is loaded: ",event.slot.getSlotElementId());}});});googletag.cmd.push(function(){googletag.pubads().addEventListener('impressionViewable',function(event){if(pubAds.dfpDebugOn()){console.log('[debug]',"showAds","impressionViewable","Slot is viewable: ",event.slot.getSlotElementId());}});});if(this.dfpDebugOn()){googletag.cmd.push(function(){googletag.pubads().addEventListener('slotRenderEnded',function(event){});});}
|
|||
|
|
if(window.location.host==='www.meetingspotlight.com'){googletag.pubads().enableSingleRequest();}
|
|||
|
|
googletag.pubads().enableLazyLoad({fetchMarginPercent:50,renderMarginPercent:30,mobileScaling:2.5});googletag.pubads().collapseEmptyDivs();googletag.enableServices();}
|
|||
|
|
floatHeadAd(time=4000){if(this.dfpDebugOn()){console.log('[debug]',"showAds","floatHeadAd","Starting head-ad float.");}
|
|||
|
|
let top=0;let headerAd=document.getElementById('header-ad-wrapper');let parent=headerAd.parentElement;parent.style.minWidth=headerAd.offsetWidth+'px';parent.style.minHeight=headerAd.offsetHeight+'px';headerAd.classList.add('float-header-ad');let toolbarNav=document.getElementById('toolbar-bar');if(toolbarNav){top+=toolbarNav.offsetHeight;}
|
|||
|
|
let adminTray=document.getElementById('toolbar-item-administration-tray');if(adminTray){top+=adminTray.offsetHeight;}
|
|||
|
|
if(top>0&&toolbarNav&&window.getComputedStyle(toolbarNav).position==='relative'){headerAd.style.top=top+'px';}
|
|||
|
|
setTimeout(function(){headerAd.classList.remove('float-header-ad');},time);}
|
|||
|
|
containerExists(elementId){return document.getElementById(elementId)!==null;}
|
|||
|
|
dfpDebugOn(){return window.location.search.indexOf("dfpdeb")>0;}}
|
|||
|
|
(function(){window.meta=new PageMeta();window.gamPath='/298443/questex.lifesciences/fiercepharma';window.pubAds=new PubAds(gamPath);window.adUnits=window.adUnits||{};if(pubAds.dfpDebugOn()){console.log("[debug] gamPath",gamPath);console.log("[debug] isArticle",meta.isArticle());console.log("[debug] section:gpt-section",meta.getMetaValue('gtm-section',0));console.log("[debug] sectionfront:gtm-section-home",meta.isSectionFront());console.log("[debug] article:gtm-is-article",meta.isArticle()?1:0);console.log("[debug] topic:gtm-topics",meta.getMetaValue('gtm-topics',''));console.log("[debug] keyword:gtm-keywords",meta.getMetaValue('gtm-keywords'));console.log("[debug] tag:gtm-tags",meta.getMetaValue('keywords'));console.log("[debug] path:Page Path",window.location.pathname);console.log("[debug] browserLargerThan1460",meta.isBrowserLarger(1460));}
|
|||
|
|
window.googletag=window.googletag||{};window.googletag.cmd=googletag.cmd||[];if(pubAds.dfpDebugOn()){console.log("[debug] pushing pubAds.define() into the googletag cmd queue");}
|
|||
|
|
pubAds.enabled=window.loadExternal;if(pubAds.enabled){googletag.cmd.push(function(){pubAds.barebonesDefine(gamPath,meta);});}})();
|
|||
|
|
]]>
|
|||
|
|
</script>
|
|||
|
|
<title>
|
|||
|
|
Novavax, eyeing the COVID 'vaccine hesitant' and kids, unveils new education campaigns as Nuvaxovid nears US finish line | Fierce Pharma
|
|||
|
|
</title>
|
|||
|
|
<meta name="parsely-metadata" content="{"isGallery":false,"uuid":"ec02b4b7-6893-47f9-8a7d-8ef55f3a9fca","bundle":"article","isSponsored":false,"mediaType":"image"}" />
|
|||
|
|
<link rel="preconnect" href="https://fonts.gstatic.com" />
|
|||
|
|
<link rel="preconnect" href="https://api.parsely.com" />
|
|||
|
|
<link rel="preconnect" href="https://qtxasset.com" />
|
|||
|
|
<style>
|
|||
|
|
<![CDATA[
|
|||
|
|
:root {
|
|||
|
|
--primary-color: #ED2028;
|
|||
|
|
--secondary-color: #00354E;
|
|||
|
|
--tertiary-color: #ED2028;
|
|||
|
|
--quaternary-color: #00354Ee6;
|
|||
|
|
--quinary-color: #c71017;
|
|||
|
|
--senary-color: #ED2028cc;
|
|||
|
|
--domain-fonts: "Overpass", sans-serif;
|
|||
|
|
--content-body-fonts: "PT Serif", serif;
|
|||
|
|
|
|||
|
|
/* ~~~ REBRAND VARIABLES ~~~ */
|
|||
|
|
--brand-1: #0D85BF;
|
|||
|
|
--brand-2: #ED2028;
|
|||
|
|
--brand-3: #00354E;
|
|||
|
|
--brand-4: #33BDFF;
|
|||
|
|
--brand-5: #0C2433;
|
|||
|
|
--brand-6: #ED2028;
|
|||
|
|
--brand-1-dark: #0b77ab;
|
|||
|
|
--brand-2-dark: #e0121a;
|
|||
|
|
--brand-gradient-1: #00354E;
|
|||
|
|
--brand-gradient-2: #0C2433;
|
|||
|
|
--brand-1-light: #0D85BF1a;
|
|||
|
|
--brand-svg-url: url("https://www.fiercepharma.com/themes/custom/quartz_barrio/images/brand/Fierce-Brand-Element.svg");
|
|||
|
|
}
|
|||
|
|
]]>
|
|||
|
|
</style>
|
|||
|
|
<meta http-equiv="origin-trial" content="AxujKG9INjsZ8/gUq8+dTruNvk7RjZQ1oFhhgQbcTJKDnZfbzSTE81wvC2Hzaf3TW4avA76LTZEMdiedF1vIbA4AAABueyJvcmlnaW4iOiJodHRwczovL2ltYXNkay5nb29nbGVhcGlzLmNvbTo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2NTI3NzQ0MDAsImlzVGhpcmRQYXJ0eSI6dHJ1ZX0=" />
|
|||
|
|
<meta http-equiv="origin-trial" content="Azuce85ORtSnWe1MZDTv68qpaW3iHyfL9YbLRy0cwcCZwVnePnOmkUJlG8HGikmOwhZU22dElCcfrfX2HhrBPAkAAAB7eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2NTI3NzQ0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9" />
|
|||
|
|
<meta http-equiv="origin-trial" content="A16nvcdeoOAqrJcmjLRpl1I6f3McDD8EfofAYTt/P/H4/AWwB99nxiPp6kA0fXoiZav908Z8etuL16laFPUdfQsAAACBeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2NTI3NzQ0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9" />
|
|||
|
|
<meta http-equiv="origin-trial" content="AxBHdr0J44vFBQtZUqX9sjiqf5yWZ/OcHRcRMN3H9TH+t90V/j3ENW6C8+igBZFXMJ7G3Pr8Dd13632aLng42wgAAACBeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiVHJ1c3RUb2tlbnMiLCJleHBpcnkiOjE2NTI3NzQ0MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9" />
|
|||
|
|
<meta http-equiv="origin-trial" content="A88BWHFjcawUfKU3lIejLoryXoyjooBXLgWmGh+hNcqMK44cugvsI5YZbNarYvi3roc1fYbHA1AVbhAtuHZflgEAAAB2eyJvcmlnaW4iOiJodHRwczovL2dvb2dsZS5jb206NDQzIiwiZmVhdHVyZSI6IlRydXN0VG9rZW5zIiwiZXhwaXJ5IjoxNjUyNzc0NDAwLCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ==" />
|
|||
|
|
<meta http-equiv="origin-trial" content="AzoawhTRDevLR66Y6MROu167EDncFPBvcKOaQispTo9ouEt5LvcBjnRFqiAByRT+2cDHG1Yj4dXwpLeIhc98/gIAAACFeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ==" />
|
|||
|
|
<meta http-equiv="origin-trial" content="A6+nc62kbJgC46ypOwRsNW6RkDn2x7tgRh0wp7jb3DtFF7oEhu1hhm4rdZHZ6zXvnKZLlYcBlQUImC4d3kKihAcAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ==" />
|
|||
|
|
<meta http-equiv="origin-trial" content="A/9La288e7MDEU2ifusFnMg1C2Ij6uoa/Z/ylwJIXSsWfK37oESIPbxbt4IU86OGqDEPnNVruUiMjfKo65H/CQwAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjYxMjk5MTk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ==" />
|
|||
|
|
<script src="https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022042801.js" async="async"></script>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.not-loaded[data-v-2243ef14]{visibility:hidden}.loaded[data-v-2243ef14]{visibility:visible}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.image-wrapper[data-v-606c2e86]{width:100%}.not-loaded[data-v-606c2e86]{visibility:hidden}.loaded[data-v-606c2e86]{visibility:visible}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.anchor[data-v-c1dedfb2]{display:block;height:115px;margin-top:-115px;visibility:hidden}.float-sidebar-ad[data-v-c1dedfb2]{position:sticky;top:95px}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.disabled[data-v-1d22d492]{cursor:not-allowed;color:gray}.hide-util-menu[data-v-1d22d492]{display:none}.show-menu[data-v-1d22d492]{display:block}.container-fluid[data-v-1d22d492]{z-index:9999}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.float-sidebar-ad[data-v-37ff9e63]{position:sticky;top:95px}.user-logged-in .float-sidebar-ad[data-v-37ff9e63]{top:174px}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.article-loader[data-v-c663d19a]{min-height:1200px}.toc-container[data-v-c663d19a]{position:-webkit-sticky;position:sticky;top:200px}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.article-loader[data-v-3cecf47e]{min-height:1200px}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.float-sidebar-ad[data-v-0ba5eb0f]{position:sticky;top:95px}.user-logged-in .float-sidebar-ad[data-v-0ba5eb0f]{top:174px}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.content-infinite-scroll-page[data-v-d5c4e7e8]{min-height:450px;background:#fff}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.container-fluid[data-v-47023996]{z-index:9999}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.float-sidebar-ad[data-v-4c659fc8]{position:sticky;top:95px}.user-logged-in .float-sidebar-ad[data-v-4c659fc8]{top:174px}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.float-sidebar-ad[data-v-78a0ee0e]{position:sticky;top:95px}.user-logged-in .float-sidebar-ad[data-v-78a0ee0e]{top:174px}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.article-loader[data-v-20865e0b]{min-height:1200px}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
.content-infinite-scroll-page[data-v-41463071]{min-height:450px;background:#fff}.float-sidebar-ad[data-v-41463071]{position:sticky;top:95px}.user-logged-in .float-sidebar-ad[data-v-41463071]{top:174px}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<style type="text/css">
|
|||
|
|
/*<![CDATA[*/
|
|||
|
|
#parsely-contextual-row {
|
|||
|
|
margin-bottom: 30px;
|
|||
|
|
margin-top: 30px;
|
|||
|
|
}
|
|||
|
|
/*]]>*/
|
|||
|
|
</style>
|
|||
|
|
<script type="text/javascript" async="async" src="https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js"></script>
|
|||
|
|
<meta http-equiv="origin-trial" content="A41wt2Lsq30A9Ox/WehogvJckPI4aY9RoSxhb8FMtVnqaUle1AtI6Yf7Wk+7+Wm0AfDDOkMX+Wn6wnDpBWYgWwYAAAB8eyJvcmlnaW4iOiJodHRwczovL2Fkcm9sbC5jb206NDQzIiwiZmVhdHVyZSI6IkludGVyZXN0Q29ob3J0QVBJIiwiZXhwaXJ5IjoxNjI2MjIwNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ==" />
|
|||
|
|
<script id="adroll_scr_exp" onerror="window.adroll_exp_list = [];" type="text/javascript" src="https://s.adroll.com/j/exp/M44CQYIBABACREQHDLDG2L/index.js"></script>
|
|||
|
|
<script type="text/javascript" src="https://s.adroll.com/j/pre/M44CQYIBABACREQHDLDG2L/V4CRMYXKKZCJLHKSSBJDQO/fpconsent.js"></script>
|
|||
|
|
<script type="text/javascript" src="https://s.adroll.com/j/pre/M44CQYIBABACREQHDLDG2L/V4CRMYXKKZCJLHKSSBJDQO/index.js"></script>
|
|||
|
|
<script type="text/javascript" src="https://d.adroll.com/consent/check/M44CQYIBABACREQHDLDG2L?arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&_s=14ed51d1579046f8bb92241c14fe339c&_b=2"></script>
|
|||
|
|
<script async="true" type="text/javascript" src="https://d.adroll.com/pixel/M44CQYIBABACREQHDLDG2L/V4CRMYXKKZCJLHKSSBJDQO?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&pv=26100603897.0754&cookie=&adroll_s_ref=&keyw="></script>
|
|||
|
|
</head>
|
|||
|
|
<body class="fiercepharma-com layout-no-sidebars has-featured-top page-node-1296731 path-node node--type-article">
|
|||
|
|
<div style="width: 1px; height: 1px; display: inline; position: absolute;">
|
|||
|
|
<img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/b/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/g/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/index/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/l/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/n/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/narrative/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/o/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/onevideo/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/outbrain/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/pubmatic/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/r/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /><img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/rakuten/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitan
|
|||
|
|
</div>
|
|||
|
|
<div style="width: 1px; height: 1px; display: inline; position: absolute;">
|
|||
|
|
<img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/r/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /> <img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/b/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /> <img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/x/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /> <img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/o/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L" /> <img height="1" width="1" style="border-style:none;" alt="" src="https://d.adroll.com/cm/g/out?adroll_fpc=ce0230ed481d4be381f2d1753d5531ea-1651697742973&arrfrr=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&advertisable=M44CQYIBABACREQHDLDG2L&google_nid=adroll5" />
|
|||
|
|
</div>
|
|||
|
|
<link rel="preload" href="https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com" as="script" />
|
|||
|
|
<script type="text/javascript" src="https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com"></script>
|
|||
|
|
<script async="async" src="//api.fouanalytics.com/s/pp.js"></script>
|
|||
|
|
<link rel="preload" href="https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com" as="script" />
|
|||
|
|
<script type="text/javascript" src="https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com"></script>
|
|||
|
|
<div class="js-active-domain-data" data-active-domain-data="{"id":"fiercepharma_com","cacheKey":"dd7249b4d4eeb2f6d385b03fe3f3f9c0"}" style="display: none"></div><noscript aria-hidden="true"><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-KLQFWCZ" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
|
|||
|
|
<div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas="">
|
|||
|
|
<div id="page-wrapper">
|
|||
|
|
<div id="page">
|
|||
|
|
<div id="main-wrapper" class="layout-main-wrapper clearfix" data-v-app="">
|
|||
|
|
<div id="main">
|
|||
|
|
<div class="row-- row-offcanvas row-offcanvas-left clearfix">
|
|||
|
|
<main class="main-content" id="content" role="main">
|
|||
|
|
<section class="section">
|
|||
|
|
<a id="main-content" tabindex="-1"></a>
|
|||
|
|
<article role="article" about="/marketing/novavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid" typeof="schema:Article" class="node node--type-article node--view-mode-full clearfix">
|
|||
|
|
<div class="node__content clearfix">
|
|||
|
|
<div class="layout layout--onecol container p-0 contained-col">
|
|||
|
|
<div class="layout__region layout__region--content">
|
|||
|
|
<div class="block block-layout-builder block-extra-field-blocknodearticlecontent-moderation-control">
|
|||
|
|
<div class="content"></div>
|
|||
|
|
</div>
|
|||
|
|
<div data-drupal-messages-fallback="" class="hidden"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="layout layout--onecol container-fluid p-0 full-width-col element-bg strong dark">
|
|||
|
|
<div class="layout__region layout__region--content">
|
|||
|
|
<div class="block block-quartz-ads">
|
|||
|
|
<div class="container p-0 ad-container">
|
|||
|
|
<div class="row justify-content-center ad-wrapper">
|
|||
|
|
<div id="interstitial-wrapper" class="ad-placement-wrapper col d-flex justify-content-center interstitial">
|
|||
|
|
<div id="interstitial" data-ad-slot="interstitial" data-google-query-id="CKnPncrdxvcCFbXgWwod9IQKIQ">
|
|||
|
|
<div id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_0__container__" style="border: 0pt none;">
|
|||
|
|
<iframe id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_0" name="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_0" title="3rd party ad content" width="1" height="1" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" role="region" aria-label="Advertisement" tabindex="0" srcdoc="" style="border: 0px; vertical-align: bottom;" data-google-container-id="1" data-load-complete="true"></iframe>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="block block-quartz-ads">
|
|||
|
|
<div class="container p-0 ad-container">
|
|||
|
|
<div class="row justify-content-center ad-wrapper">
|
|||
|
|
<div id="mobile-adhesion-wrapper" class="ad-placement-wrapper col d-flex justify-content-center mobile-adhesion">
|
|||
|
|
<div id="mobile-adhesion" data-ad-slot="mobile-adhesion" data-google-query-id="CKrPncrdxvcCFbXgWwod9IQKIQ">
|
|||
|
|
<div id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_1__container__" style="border: 0pt none;">
|
|||
|
|
<iframe id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_1" name="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_1" title="3rd party ad content" width="1" height="1" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" role="region" aria-label="Advertisement" tabindex="0" srcdoc="" style="border: 0px; vertical-align: bottom;" data-google-container-id="2" data-load-complete="true"></iframe>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="block block-quartz-ads">
|
|||
|
|
<div class="container p-0 ad-container">
|
|||
|
|
<div class="row justify-content-center ad-wrapper">
|
|||
|
|
<div id="wallpaper-wrapper" class="ad-placement-wrapper col d-flex justify-content-center wallpaper" style="min-width: 1px; min-height: 1px;">
|
|||
|
|
<div id="wallpaper" data-ad-slot="wallpaper" data-google-query-id="CJW8l8vdxvcCFT0B-QAdO0EOaQ" style="display: none;">
|
|||
|
|
<div id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_2__container__" style="border: 0pt none; width: 1600px; height: 0px;"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="block block-quartz-ads" style="min-height: 90px;">
|
|||
|
|
<div class="container p-0 ad-container">
|
|||
|
|
<div class="row justify-content-center ad-wrapper">
|
|||
|
|
<div id="header-ad-wrapper" class="ad-placement-wrapper col d-flex justify-content-center header-ad" style="min-width: 1px; min-height: 1px;">
|
|||
|
|
<div id="header-ad" data-ad-slot="header-ad" data-google-query-id="CJa8l8vdxvcCFT0B-QAdO0EOaQ">
|
|||
|
|
<div id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_3__container__" style="border: 0pt none;">
|
|||
|
|
<iframe id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_3" name="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_3" title="3rd party ad content" width="970" height="90" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" role="region" aria-label="Advertisement" tabindex="0" srcdoc="" data-google-container-id="6" style="border: 0px; vertical-align: bottom;" data-load-complete="true"></iframe>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="layout layout--onecol container-fluid p-0 full-width-col">
|
|||
|
|
<div class="layout__region layout__region--content">
|
|||
|
|
<div class="block block-quartz-blocks block-quartz-blocks-header header__wrapper p-0">
|
|||
|
|
<div class="content">
|
|||
|
|
<header role="banner" class="header--large d-none d-lg-block">
|
|||
|
|
<div class="brand-bar element-bg strong dark js-header-utility-large d-flex align-items-center">
|
|||
|
|
<div class="container-fluid brand-menu-wrapper">
|
|||
|
|
<div class="row justify-content-between align-items-center">
|
|||
|
|
<div class="col">
|
|||
|
|
<ul class="clearfix nav">
|
|||
|
|
<li class="current-site nav-item">
|
|||
|
|
<a href="https://www.fiercepharma.com/" class="nav-link nav-link-https--wwwfiercepharmacom-">Fierce Pharma</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercebiotech.com/" class="nav-link nav-link-https--wwwfiercebiotechcom-">Fierce Biotech</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercehealthcare.com/" class="nav-link nav-link-https--wwwfiercehealthcarecom-">Fierce Healthcare</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercelifesciences.com/" title="Life Sciences Events" class="nav-link nav-link-https--wwwfiercelifesciencescom-">Fierce Life Sciences Events</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-auto social-wrapper d-flex align-items-center justify-content-end">
|
|||
|
|
<div class="social">
|
|||
|
|
<a class="linkedin" href="https://www.linkedin.com/showcase/fierce-pharma/" aria-label="LinkedIn" target="_blank"><svg aria-hidden="true" focusable="false" data-prefix="fab" data-icon="linkedin-in" class="svg-inline--fa fa-linkedin-in fa-w-14" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 448 512">
|
|||
|
|
<path fill="currentColor" d="M100.28 448H7.4V148.9h92.88zM53.79 108.1C24.09 108.1 0 83.5 0 53.8a53.79 53.79 0 0 1 107.58 0c0 29.7-24.1 54.3-53.79 54.3zM447.9 448h-92.68V302.4c0-34.7-.7-79.2-48.29-79.2-48.29 0-55.69 37.7-55.69 76.7V448h-92.78V148.9h89.08v40.8h1.3c12.4-23.5 42.69-48.3 87.88-48.3 94 0 111.28 61.9 111.28 142.3V448z"></path></svg></a><a class="twitter" href="https://twitter.com/fiercepharma" aria-label="Twitter" target="_blank"><svg aria-hidden="true" focusable="false" data-prefix="fab" data-icon="twitter" class="svg-inline--fa fa-twitter fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 512 512">
|
|||
|
|
<path fill="currentColor" d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"></path></svg></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="main-nav d-flex align-items-center">
|
|||
|
|
<div class="container-fluid js-main-menu-sub-container justify-content-center main-menu-wrapper float-menu hide-menu">
|
|||
|
|
<div class="row menu-content align-items-center">
|
|||
|
|
<div class="col-auto pl-0">
|
|||
|
|
<div class="header-logo">
|
|||
|
|
<div class="logo" style="min-height: 40px; min-width: 100px;">
|
|||
|
|
<a href="/" rel="home"><img src="https://qtxasset.com/quartz/qcloud5/FP21%20Logo.svg" alt="Home" style="min-height: 40px;" /></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="row justify-content-between align-items-center">
|
|||
|
|
<div class="col p-0 menu-items-wrapper">
|
|||
|
|
<div class="row justify-content-between align-items-center">
|
|||
|
|
<div class="header-link-group col p-0">
|
|||
|
|
<ul class="clearfix nav">
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<a href="/manufacturing" title="Manufacturing" class="nav-link nav-link--manufacturing" data-drupal-link-system-path="taxonomy/term/104741">Manufacturing</a>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/facilites" class="nav-link nav-link--facilites">Facilities</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/recalls" class="nav-link nav-link--recalls" data-drupal-link-system-path="taxonomy/term/133516">Recalls</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/marketing" title="Marketing" class="nav-link nav-link--marketing" data-drupal-link-system-path="taxonomy/term/104746">Marketing</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<a href="/pharma" title="Pharma" class="nav-link nav-link--pharma" data-drupal-link-system-path="taxonomy/term/104751">Pharma</a>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/asia" title="Asia" class="nav-link nav-link--asia" data-drupal-link-system-path="taxonomy/term/104721">Asia</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/keyword/drug-delivery" title="Drug Delivery" class="nav-link nav-link--keyword-drug-delivery" data-drupal-link-system-path="taxonomy/term/87086">Drug Delivery</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/executives" class="nav-link nav-link--executives" data-drupal-link-system-path="taxonomy/term/133531">Executives</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/clinical-data" class="nav-link nav-link--clinical-data" data-drupal-link-system-path="taxonomy/term/51711">Clinical Data</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/vaccines" title="Vaccines" class="nav-link nav-link--vaccines" data-drupal-link-system-path="taxonomy/term/104756">Vaccines</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/special-reports" title="Special Reports" class="nav-link nav-link--special-reports" data-drupal-link-system-path="taxonomy/term/4026">Special Reports</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<a href="" title="Trending Topics" class="nav-link nav-link-">Trending</a>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/keyword/covid-19" title="COVID-19" class="nav-link nav-link--keyword-covid-19" data-drupal-link-system-path="taxonomy/term/50296">COVID-19</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/keyword/cell-gene-therapy" title="Cell & Gene Therapy" class="nav-link nav-link--keyword-cell-gene-therapy" data-drupal-link-system-path="taxonomy/term/101066">Cell & Gene Therapy</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/keyword/consumer-health" title="Consumer Health" class="nav-link nav-link--keyword-consumer-health" data-drupal-link-system-path="taxonomy/term/50926">Consumer Health</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/podcasts" class="nav-link nav-link--podcasts" data-drupal-link-system-path="node/1304286">Podcasts</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</div>
|
|||
|
|
<div class="header-link-group col-auto p-0 pr-lg-4">
|
|||
|
|
<ul class="clearfix nav">
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<a href="/resources" title="Resources" class="nav-link nav-link--resources" data-drupal-link-system-path="node/31">Resources</a>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/resource/products/event" title="Events" class="nav-link nav-link--resource-products-event" data-drupal-link-system-path="resource/products/event">Events</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/resource/products/webinar" title="Webinars" class="nav-link nav-link--resource-products-webinar" data-drupal-link-system-path="resource/products/webinar">Webinars</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/resource/products/podcast" class="nav-link nav-link--resource-products-podcast" data-drupal-link-system-path="resource/products/podcast">Podcasts</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item highlighted-link">
|
|||
|
|
<a href="https://fiercepharma.questexinfo.com/loading.do?omedasite=Pharma_full" title="Subscribe" class="nav-link nav-link-https--fiercepharmaquestexinfocom-loadingdoomedasitepharma-full">Subscribe</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-auto pl-3 d-flex align-items-center search-wrapper">
|
|||
|
|
<div id="search-modal-icon" class="search open-icon float-right">
|
|||
|
|
<a class="search-icon-link search-modal-toggle"><img src="/themes/custom/quartz_barrio/images/icons/search-regular.svg" alt="Search Icon" style="min-width: 16px; width: 16px; height: 16px;" /></a>
|
|||
|
|
</div>
|
|||
|
|
<div class="search-form-modal modal modal-fullscreen p-0">
|
|||
|
|
<div class="modal-dialog w-100 h-100 m-0">
|
|||
|
|
<div class="modal-content border-0 rounded-0 h-100 gray-bg">
|
|||
|
|
<div class="modal-body">
|
|||
|
|
<form action="/search-results" method="get">
|
|||
|
|
<div class="container">
|
|||
|
|
<div class="row mb-4">
|
|||
|
|
<div class="col-11">
|
|||
|
|
<div class="text-left element-title xlarge">
|
|||
|
|
What are you searching for?
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-1 search-dismiss align-items-center d-flex justify-content-end">
|
|||
|
|
<button type="button" data-dismiss="modal" class="search-modal-toggle"><img src="/themes/custom/quartz_barrio/images/icons/times-regular.svg" alt="Dismiss search modal" style="min-width: 30px;" /></button>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row search-form mb-4">
|
|||
|
|
<div class="col d-flex align-items-center">
|
|||
|
|
<button class="position-absolute search-modal-submit" type="submit"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 512 512">
|
|||
|
|
<path fill="currentColor" d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z"></path></svg></button><input type="text" placeholder="Search" name="fulltext_search" class="w-100 search-modal-input" />
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row search-help-text font-weight-light text-align-left">
|
|||
|
|
<div class="col-md-10">
|
|||
|
|
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.<br />
|
|||
|
|
Example: +water -Europe
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</form>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</header>
|
|||
|
|
<header role="banner" class="mobile-nav container-fluid d-lg-none js-mobile-menu-sub-container float-menu hide-menu">
|
|||
|
|
<div class="header-bar row align-items-center justify-content-between">
|
|||
|
|
<div class="header-logo d-flex col-6 col-md-4">
|
|||
|
|
<div class="logo" style="min-height: 40px; min-width: 100px;">
|
|||
|
|
<a href="/" rel="home"><img src="https://qtxasset.com/quartz/qcloud5/FP21%20Logo.svg" alt="Home" style="min-height: 40px;" /></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-4 col-md-7 p-0 pr-md-4">
|
|||
|
|
<div class="highlighted-link d-flex justify-content-end">
|
|||
|
|
<a href="https://fiercepharma.questexinfo.com/loading.do?omedasite=Pharma_full">Subscribe</a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-auto header-toggle-wrapper d-flex justify-content-end pl-0">
|
|||
|
|
<div class="header-toggle">
|
|||
|
|
<a class="toggle-icon mobile-menu-open closed active"><img src="/themes/custom/quartz_barrio/images/icons/bars-regular.svg" alt="Hamburger Menu" style="min-width: 30px; width: 30px; height: 34px;" /></a><a class="toggle-icon mobile-menu-close open"><img src="/themes/custom/quartz_barrio/images/icons/times-regular.svg" alt="Hamburger Menu" style="min-width: 30px;" /></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="header-dropdown row">
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="search-form-wrapper container mt-3">
|
|||
|
|
<form action="/search-results" class="search-form row d-flex align-items-center position-relative" method="get">
|
|||
|
|
<div class="col-auto px-2 d-flex justify-content-center align-items-center position-absolute" style="z-index: 1;">
|
|||
|
|
<button type="submit"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 512 512">
|
|||
|
|
<path fill="currentColor" d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z"></path></svg></button>
|
|||
|
|
</div>
|
|||
|
|
<div class="col p-0">
|
|||
|
|
<input type="text" placeholder="Search" name="fulltext_search" class="w-100 gray-bg font-weight-medium" />
|
|||
|
|
</div>
|
|||
|
|
</form>
|
|||
|
|
</div>
|
|||
|
|
<div class="header-menu--main">
|
|||
|
|
<div class="header-link-group col p-0">
|
|||
|
|
<ul class="clearfix nav">
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<a href="/manufacturing" title="Manufacturing" class="nav-link nav-link--manufacturing" data-drupal-link-system-path="taxonomy/term/104741">Manufacturing</a>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/facilites" class="nav-link nav-link--facilites">Facilities</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/recalls" class="nav-link nav-link--recalls" data-drupal-link-system-path="taxonomy/term/133516">Recalls</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
<div class="sub-nav-toggle"></div>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/marketing" title="Marketing" class="nav-link nav-link--marketing" data-drupal-link-system-path="taxonomy/term/104746">Marketing</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<a href="/pharma" title="Pharma" class="nav-link nav-link--pharma" data-drupal-link-system-path="taxonomy/term/104751">Pharma</a>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/asia" title="Asia" class="nav-link nav-link--asia" data-drupal-link-system-path="taxonomy/term/104721">Asia</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/keyword/drug-delivery" title="Drug Delivery" class="nav-link nav-link--keyword-drug-delivery" data-drupal-link-system-path="taxonomy/term/87086">Drug Delivery</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/executives" class="nav-link nav-link--executives" data-drupal-link-system-path="taxonomy/term/133531">Executives</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/clinical-data" class="nav-link nav-link--clinical-data" data-drupal-link-system-path="taxonomy/term/51711">Clinical Data</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
<div class="sub-nav-toggle"></div>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/vaccines" title="Vaccines" class="nav-link nav-link--vaccines" data-drupal-link-system-path="taxonomy/term/104756">Vaccines</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/special-reports" title="Special Reports" class="nav-link nav-link--special-reports" data-drupal-link-system-path="taxonomy/term/4026">Special Reports</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<a href="" title="Trending Topics" class="nav-link nav-link-">Trending</a>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/keyword/covid-19" title="COVID-19" class="nav-link nav-link--keyword-covid-19" data-drupal-link-system-path="taxonomy/term/50296">COVID-19</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/keyword/cell-gene-therapy" title="Cell & Gene Therapy" class="nav-link nav-link--keyword-cell-gene-therapy" data-drupal-link-system-path="taxonomy/term/101066">Cell & Gene Therapy</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/keyword/consumer-health" title="Consumer Health" class="nav-link nav-link--keyword-consumer-health" data-drupal-link-system-path="taxonomy/term/50926">Consumer Health</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
<div class="sub-nav-toggle"></div>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/podcasts" class="nav-link nav-link--podcasts" data-drupal-link-system-path="node/1304286">Podcasts</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</div>
|
|||
|
|
<div class="header-link-group col-auto p-0 pr-lg-4">
|
|||
|
|
<ul class="clearfix nav">
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<a href="/resources" title="Resources" class="nav-link nav-link--resources" data-drupal-link-system-path="node/31">Resources</a>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/resource/products/event" title="Events" class="nav-link nav-link--resource-products-event" data-drupal-link-system-path="resource/products/event">Events</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/resource/products/webinar" title="Webinars" class="nav-link nav-link--resource-products-webinar" data-drupal-link-system-path="resource/products/webinar">Webinars</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/resource/products/podcast" class="nav-link nav-link--resource-products-podcast" data-drupal-link-system-path="resource/products/podcast">Podcasts</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
<div class="sub-nav-toggle"></div>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item highlighted-link">
|
|||
|
|
<a href="https://fiercepharma.questexinfo.com/loading.do?omedasite=Pharma_full" title="Subscribe" class="nav-link nav-link-https--fiercepharmaquestexinfocom-loadingdoomedasitepharma-full">Subscribe</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="mobile-brand-bar header-utility-small element-bg alt row">
|
|||
|
|
<div class="col-12 utility-menu">
|
|||
|
|
<ul class="clearfix nav">
|
|||
|
|
<li class="current-site nav-item">
|
|||
|
|
<a href="https://www.fiercepharma.com/" class="nav-link nav-link-https--wwwfiercepharmacom-">Fierce Pharma</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercebiotech.com/" class="nav-link nav-link-https--wwwfiercebiotechcom-">Fierce Biotech</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercehealthcare.com/" class="nav-link nav-link-https--wwwfiercehealthcarecom-">Fierce Healthcare</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercelifesciences.com/" title="Life Sciences Events" class="nav-link nav-link-https--wwwfiercelifesciencescom-">Fierce Life Sciences Events</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-12">
|
|||
|
|
<div class="social">
|
|||
|
|
<a class="linkedin" href="https://www.linkedin.com/showcase/fierce-pharma/" aria-label="LinkedIn" target="_blank"><svg aria-hidden="true" focusable="false" data-prefix="fab" data-icon="linkedin-in" class="svg-inline--fa fa-linkedin-in fa-w-14" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 448 512">
|
|||
|
|
<path fill="currentColor" d="M100.28 448H7.4V148.9h92.88zM53.79 108.1C24.09 108.1 0 83.5 0 53.8a53.79 53.79 0 0 1 107.58 0c0 29.7-24.1 54.3-53.79 54.3zM447.9 448h-92.68V302.4c0-34.7-.7-79.2-48.29-79.2-48.29 0-55.69 37.7-55.69 76.7V448h-92.78V148.9h89.08v40.8h1.3c12.4-23.5 42.69-48.3 87.88-48.3 94 0 111.28 61.9 111.28 142.3V448z"></path></svg></a><a class="twitter" href="https://twitter.com/fiercepharma" aria-label="Twitter" target="_blank"><svg aria-hidden="true" focusable="false" data-prefix="fab" data-icon="twitter" class="svg-inline--fa fa-twitter fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 512 512">
|
|||
|
|
<path fill="currentColor" d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"></path></svg></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</header>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="layout layout--onecol container-fluid p-0 full-width-col">
|
|||
|
|
<div class="layout__region layout__region--content">
|
|||
|
|
<div class="block block-quartz-apifirst block-quartz-apifirst-article-gallery-full-progressive">
|
|||
|
|
<div class="content"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="layout layout--onecol container-fluid p-0 full-width-col">
|
|||
|
|
<div class="layout__region layout__region--content">
|
|||
|
|
<div id="infs-content-meta" data-uuid="ec02b4b7-6893-47f9-8a7d-8ef55f3a9fca" style="display: none;"></div>
|
|||
|
|
<div style="min-height: 1500px;">
|
|||
|
|
<div id="article-container" class="container-fluid p-0" body="" data-v-0ba5eb0f="" data-url="https://www.fiercepharma.com/marketing/novavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid">
|
|||
|
|
<!---->
|
|||
|
|
<div class="container-fluid p-0 element-bg gradient position-relative dark" data-v-0ba5eb0f="" style="min-height: 491px;">
|
|||
|
|
<img src="https://www.fiercepharma.com/themes/custom/quartz_barrio/images/brand/Fierce-Brand-Element.svg" />
|
|||
|
|
<div class="container" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-8 col-xl-9" data-v-0ba5eb0f="" style="margin-top: 79px; margin-bottom: 118px;">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-1" data-v-0ba5eb0f="">
|
|||
|
|
<div class="social-share" data-v-0ba5eb0f="">
|
|||
|
|
<div class="container p-0 mt-3 large-social" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row mb-4">
|
|||
|
|
<div class="col d-flex justify-content-center">
|
|||
|
|
<a class="share-network-linkedin linkedin" href="javascript:void(0)"><i><svg aria-hidden="true" focusable="false" data-prefix="fab" data-icon="linkedin-in" class="svg-inline--fa fa-linkedin-in" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 448 512">
|
|||
|
|
<path fill="currentColor" d="M100.28 448H7.4V148.9h92.88zM53.79 108.1C24.09 108.1 0 83.5 0 53.8a53.79 53.79 0 0 1 107.58 0c0 29.7-24.1 54.3-53.79 54.3zM447.9 448h-92.68V302.4c0-34.7-.7-79.2-48.29-79.2-48.29 0-55.69 37.7-55.69 76.7V448h-92.78V148.9h89.08v40.8h1.3c12.4-23.5 42.69-48.3 87.88-48.3 94 0 111.28 61.9 111.28 142.3V448z"></path></svg></i></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row mb-4">
|
|||
|
|
<div class="col d-flex justify-content-center">
|
|||
|
|
<a class="share-network-twitter twitter" href="javascript:void(0)"><i><svg aria-hidden="true" focusable="false" data-prefix="fab" data-icon="twitter" class="svg-inline--fa fa-twitter" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 512 512">
|
|||
|
|
<path fill="currentColor" d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"></path></svg></i></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row mb-4">
|
|||
|
|
<div class="col d-flex justify-content-center">
|
|||
|
|
<a class="share-network-facebook facebook" href="javascript:void(0)"><i><svg aria-hidden="true" focusable="false" data-prefix="fab" data-icon="facebook-f" class="svg-inline--fa fa-facebook-f" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 320 512">
|
|||
|
|
<path fill="currentColor" d="M279.14 288l14.22-92.66h-88.91v-60.13c0-25.35 12.42-50.06 52.24-50.06h40.42V6.26S260.43 0 225.36 0c-73.22 0-121.08 44.38-121.08 124.72v70.62H22.89V288h81.39v224h100.17V288z"></path></svg></i></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row mb-4">
|
|||
|
|
<div class="col d-flex justify-content-center">
|
|||
|
|
<a class="share-network-email email" href="javascript:void(0)"><i><svg xmlns="http://www.w3.org/2000/svg" data-icon="envelope-regular" class="svg-inline--fa fa-envelope" role="img" viewbox="0 0 512 512"><!--! Font Awesome Pro 6.1.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license (Commercial License) Copyright 2022 Fonticons, Inc. -->
|
|||
|
|
<path fill="currentColor" d="M0 128C0 92.65 28.65 64 64 64H448C483.3 64 512 92.65 512 128V384C512 419.3 483.3 448 448 448H64C28.65 448 0 419.3 0 384V128zM48 128V150.1L220.5 291.7C241.1 308.7 270.9 308.7 291.5 291.7L464 150.1V127.1C464 119.2 456.8 111.1 448 111.1H64C55.16 111.1 48 119.2 48 127.1L48 128zM48 212.2V384C48 392.8 55.16 400 64 400H448C456.8 400 464 392.8 464 384V212.2L322 328.8C283.6 360.3 228.4 360.3 189.1 328.8L48 212.2z"></path></svg></i></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row mb-4">
|
|||
|
|
<div class="col d-flex justify-content-center">
|
|||
|
|
<a href="https://www.fiercepharma.com/marketing/novavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid" rel="nofollow"><i><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="link" class="svg-inline--fa fa-link fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 512 512">
|
|||
|
|
<path fill="currentColor" d="M314.222 197.78c51.091 51.091 54.377 132.287 9.75 187.16-6.242 7.73-2.784 3.865-84.94 86.02-54.696 54.696-143.266 54.745-197.99 0-54.711-54.69-54.734-143.255 0-197.99 32.773-32.773 51.835-51.899 63.409-63.457 7.463-7.452 20.331-2.354 20.486 8.192a173.31 173.31 0 0 0 4.746 37.828c.966 4.029-.272 8.269-3.202 11.198L80.632 312.57c-32.755 32.775-32.887 85.892 0 118.8 32.775 32.755 85.892 32.887 118.8 0l75.19-75.2c32.718-32.725 32.777-86.013 0-118.79a83.722 83.722 0 0 0-22.814-16.229c-4.623-2.233-7.182-7.25-6.561-12.346 1.356-11.122 6.296-21.885 14.815-30.405l4.375-4.375c3.625-3.626 9.177-4.594 13.76-2.294 12.999 6.524 25.187 15.211 36.025 26.049zM470.958 41.04c-54.724-54.745-143.294-54.696-197.99 0-82.156 82.156-78.698 78.29-84.94 86.02-44.627 54.873-41.341 136.069 9.75 187.16 10.838 10.838 23.026 19.525 36.025 26.049 4.582 2.3 10.134 1.331 13.76-2.294l4.375-4.375c8.52-8.519 13.459-19.283 14.815-30.405.621-5.096-1.938-10.113-6.561-12.346a83.706 83.706 0 0 1-22.814-16.229c-32.777-32.777-32.718-86.065 0-118.79l75.19-75.2c32.908-32.887 86.025-32.755 118.8 0 32.887 32.908 32.755 86.025 0 118.8l-45.848 45.84c-2.93 2.929-4.168 7.169-3.202 11.198a173.31 173.31 0 0 1 4.746 37.828c.155 10.546 13.023 15.644 20.486 8.192 11.574-11.558 30.636-30.684 63.409-63.457 54.733-54.735 54.71-143.3-.001-197.991z"></path></svg></i><!----></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-lg-11" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-12">
|
|||
|
|
<div class="row mb-3">
|
|||
|
|
<a name="ec02b4b7-6893-47f9-8a7d-8ef55f3a9fca" style="margin-top: -80px;" id="ec02b4b7-6893-47f9-8a7d-8ef55f3a9fca"></a>
|
|||
|
|
<div class="col-12">
|
|||
|
|
<div class="label">
|
|||
|
|
<!----><!----><!----><!----><span><a href="/marketing">Marketing</a></span><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div id="article-head-row" class="row" style="min-height: 120px;" data-ga-read-title-recorded="1">
|
|||
|
|
<div class="col-12">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col-12">
|
|||
|
|
<h1 class="element-title hero">
|
|||
|
|
Novavax, eyeing the COVID 'vaccine hesitant' and kids, unveils new education campaigns as Nuvaxovid nears US finish line
|
|||
|
|
</h1>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row mb-4">
|
|||
|
|
<div class="col-12">
|
|||
|
|
<div class="byline">
|
|||
|
|
<span>By <a href="/person/ben-adams" rel="bookmark"><!----><span class="font-weight-bold">Ben Adams</span></a></span><span class="dot d-none d-md-inline"><i><svg style="font-size: 4px; margin-bottom: 3px;" aria-hidden="true" focusable="false" data-prefix="fas" data-icon="circle" class="svg-inline--fa fa-circle" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 512 512">
|
|||
|
|
<path fill="currentColor" d="M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8z"></path></svg></i></span><span class="date d-block d-md-inline-block">Mar 10, 2022 05:30am</span>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div id="article-tags-row" class="row article-tags mb-3 mb-lg-5">
|
|||
|
|
<div class="col-12 mb-4">
|
|||
|
|
<a href="/keyword/novavax" class="tag">Novavax</a><a href="/keyword/covid-19" class="tag">COVID-19</a><a href="/keyword/pfizer" class="tag">Pfizer</a><a href="/keyword/moderna" class="tag">Moderna</a><!----><!----><!----><!----><!----><!----><!----><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="container" data-v-0ba5eb0f="" style="min-height: 1500px;">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-8 col-xl-9" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-11 offset-lg-1" data-v-0ba5eb0f="" style="margin-top: -118px;">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-12">
|
|||
|
|
<!---->
|
|||
|
|
<div id="article-media-row" class="row media media-content-image" data-ga-read-media-recorded="1">
|
|||
|
|
<div class="col-12">
|
|||
|
|
<figure class="figure">
|
|||
|
|
<figure class="image-wrapper" data-v-2243ef14="">
|
|||
|
|
<img src="https://qtxasset.com/cdn-cgi/image/w=850,h=478,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/Novavaximage.png?VersionId=f9UDAFMgagg4Y_igFXWmnc3TJKOoTl_k" alt="Novavax" width="850" height="478" class="img-fluid img-fluid figure-img" data-v-2243ef14="" />
|
|||
|
|
</figure>
|
|||
|
|
<figcaption class="caption text-align-left mt-4" style="min-height: 40px;">
|
|||
|
|
Novavax is betting its reliance on traditional vaccine technology can bring several missed population groups back on board for their COVID shots. (Novavax )
|
|||
|
|
</figcaption>
|
|||
|
|
</figure><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div id="article-body-row" class="row media-content-body mb-lg-4 mt-4" data-v-0ba5eb0f="" data-ga-read-body-start-recorded="1">
|
|||
|
|
<!---->
|
|||
|
|
<div class="col content">
|
|||
|
|
<p>
|
|||
|
|
Pfizer, Moderna and Johnson & Johnson were quickest off the mark in getting COVID vaccines into American arms, but Novavax is hoping to add another pandemic vaccine to the U.S. mix soon—and it's pushing new campaigns to get the word out.
|
|||
|
|
</p>
|
|||
|
|
<div class="container p-0 ad-container">
|
|||
|
|
<div class="row justify-content-center ad-wrapper">
|
|||
|
|
<div id="contentEmbedOne1651697742435-wrapper" class="ad-placement-wrapper col d-flex justify-content-center contentEmbedOne1651697742435">
|
|||
|
|
<div id="contentEmbedOne1651697742435" data-ad-slot="contentEmbedOne1651697742435" data-google-query-id="CKzPncrdxvcCFbXgWwod9IQKIQ">
|
|||
|
|
<div id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_8__container__" style="border: 0pt none;">
|
|||
|
|
<iframe id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_8" name="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_8" title="3rd party ad content" width="1" height="1" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" role="region" aria-label="Advertisement" tabindex="0" srcdoc="" style="border: 0px; vertical-align: bottom;" data-google-container-id="4" data-load-complete="true"></iframe>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<p>
|
|||
|
|
The biopharma, which has approvals and authorizations in Europe and around the world, is now on the cusp of a potential green light in the U.S. And with a market comes the need for marketing.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
But because it still has no U.S. approval—and it cannot under law advertise to consumers in Europe—Novavax is launching two new global, unbranded vaccine education programs: "We Do Vaccines" and "Know Our Vax." They're designed to offer up vaccine information and "explain Novavax’ commitment to vaccine development and innovation,” the company told Fierce Pharma Marketing.
|
|||
|
|
</p>
|
|||
|
|
<div class="mobile-ad"></div>
|
|||
|
|
<div id="omeda-promo-article-inline-after-p3" class="olytics_injection olyticsPopupBR">
|
|||
|
|
<div style="padding: 50px 0; margin: 50px 0; border-top: 1px solid #BEBEBE; border-bottom: 1px solid #BEBEBE;">
|
|||
|
|
<p style="font-style: normal; font-weight: 600; font-size: 12px; line-height: 16px; text-transform: uppercase; color: #4c4c4c; padding-bottom: 10px; margin: 0;">
|
|||
|
|
Webinar: Tuesday, may 10, 2022 | 2Pm ET / 11am PT
|
|||
|
|
</p>
|
|||
|
|
<h3 style="font-weight: 800; font-size: 26px; line-height: 32px; color: #212121; padding-bottom: 10px; margin: 0;">
|
|||
|
|
<a onclick="olytics.clickGo(this,'https://pages.questexinfo.com/honeywell-registration-04132022/?pk=fp-inline');" style="cursor:pointer;cursor: pointer; font-weight: 800; font-size: 26px; line-height: 32px; color: #212121; padding-bottom: 10px; margin: 0; text-decoration: none;" class="element-title" target="_blank">Improving Commercial Effectiveness at Novartis</a>
|
|||
|
|
</h3>
|
|||
|
|
<p style="font-weight: normal; font-size: 16px; line-height: 24px; color: #212121; margin: 0; padding-bottom: 10px;">
|
|||
|
|
Sponsored by <span style="font-weight: 600;">Snowflake</span>
|
|||
|
|
</p>
|
|||
|
|
<p style="font-weight: normal; font-size: 16px; line-height: 24px; color: #212121; margin: 0; padding-bottom: 20px;">
|
|||
|
|
Join this session to learn how Novartis is using Snowflake's Data Cloud to achieve interoperability across multitudes of vendors, systems, and data sources, empower innovation and improve effectiveness for analytics and data science teams by removing data bottlenecks and barriers to insight, and enable a global data strategy by leveraging multi-cloud capabilities.
|
|||
|
|
</p><a onclick="olytics.clickGo(this,'https://pages.questexinfo.com/snowflake-registration-5102022/?pk=FP-inline');" style="cursor:pointer;cursor: pointer; padding: 10px 24px; font-size: 16px; line-height: 22px; font-weight: 500; color: #ffffff;" class="button" target="_blank">Register Now</a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<p>
|
|||
|
|
The main message of the campaign is that “people have options when it comes to their vaccine,” Silvia Taylor, senior vice president of global corporate affairs at Novavax, said in an interview. “We want people to understand that we have this vaccine, and that this vaccine is different.”
|
|||
|
|
</p>
|
|||
|
|
<div data-embed-button="node" data-entity-embed-display="view_mode:node.related_content" data-entity-type="node" data-entity-uuid="4ba732ba-8a0c-43f5-bed9-e0aa30cff883" data-langcode="en" class="embedded-entity">
|
|||
|
|
<div class="container-fluid p-0">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col">
|
|||
|
|
<h3 class="label">
|
|||
|
|
Related
|
|||
|
|
</h3>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col title font-weight-extra-bold">
|
|||
|
|
<a href="/pharma/citing-risk-potentially-deadly-blood-clots-cdc-vaccine-advisors-recommend-mrna-pandemic" rel="bookmark"><span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Citing blood clot risks, CDC advisers recommend mRNA pandemic vaccines over J&J shot</span></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<p>
|
|||
|
|
Novavax knows it has some tough competition—Pfizer and Moderna's vaccines dominate the U.S. market—but the small biotech is eyeing certain market niches: The "vaccine hesitant" who might be leery of the brand-new mRNA tech in Pfizer and Moderna's shots, and children. And it does have a strong, vocal following online that's eagerly awaiting a U.S. decision.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
Nuvaxovid taps older tech that's been used in influenza shots and others for decades. The vaccine contains a version of the SARS-CoV-2 spike protein made in the lab as well as an adjuvant, which is a booster ingredient designed to strengthen immune responses to the vaccine.
|
|||
|
|
</p>
|
|||
|
|
<div class="mobile-ad"></div>
|
|||
|
|
<h3>
|
|||
|
|
A new option
|
|||
|
|
</h3>
|
|||
|
|
<p>
|
|||
|
|
Pfizer and Moderna's shots obviously weren't the only two vaccines in the U.S.: Johnson & Johnson’s single-dose vaccine alternative also uses older vaccine technology. But it fell out of favor amid weakening efficacy and major manufacturing issues. Then, late last year, a Centers for Disease Control and Prevention panel recommended it <a href="https://www.fiercepharma.com/pharma/citing-risk-potentially-deadly-blood-clots-cdc-vaccine-advisors-recommend-mrna-pandemic">should be sidelined</a> because of serious safety concerns.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
AstraZeneca's COVID vaccine—which itself uses more traditional vaccine technology—hasn’t been approved in the U.S. 
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
Enter Novavax, now looking to position its vaccine as an mRNA alternative.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
People hesitant about vaccinations may not want an mRNA vaccine because it's new technology, without years of proven safety behind it. But they might use an older, “tried and tested” tech, as Novavax puts it.  
|
|||
|
|
</p>
|
|||
|
|
<div id="omeda-promo-article-inline-after-p10" class="olytics_injection olyticsPopupBR">
|
|||
|
|
<div style="max-width: 800px; margin: 40px 0; display: flex;">
|
|||
|
|
<div style="width: 180px; height: auto; background-image: linear-gradient(0deg, rgba(13, 133, 191, .7), rgba(13, 133, 191, .7)), url('https://s3.amazonaws.com/publicaudience.qtxasset.com/Life+Science/Pharma__MG_0691.JPG'); background-size: cover; background-position: 70% 10%;">
|
|||
|
|
<div style="height: 100%; width: 100%; display: flex; justify-content: center; align-items: center;">
|
|||
|
|
<img style="max-width: 100px; max-height: 75px;" src="https://s3.amazonaws.com/publicaudience.qtxasset.com/Life+Science/Events/DPE/2022/DPE-white-type.svg" alt="digital pharma east logo" />
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div style="width: 640px; background-color: #f4f4f4; display: flex; padding: 20px; justify-content: space-between; align-items: center;">
|
|||
|
|
<div style="max-width: 380px;">
|
|||
|
|
<p style="font-weight: normal; font-size: 12px; line-height: 16px; text-transform: uppercase; padding-bottom: 5px; margin: 0;">
|
|||
|
|
Fierce Event
|
|||
|
|
</p>
|
|||
|
|
<h4 style="font-weight: 900; font-size: 26px; line-height: 32px; padding-bottom: 10px; margin: 0;">
|
|||
|
|
Register now for early-bird savings!
|
|||
|
|
</h4>
|
|||
|
|
<div style="display: flex; opacity: .7; flex-direction: column;">
|
|||
|
|
<div style="display: flex; align-items: center; padding-right: 10px;">
|
|||
|
|
<svg style="enable-background: new 0 0 448 512; height: 14px;" viewbox="0 0 448 512" xmlns="http://www.w3.org/2000/svg">
|
|||
|
|
<path style="fill: #212121;" d="M400 64h-48V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H160V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H48C21.5 64 0 85.5 0 112v352c0 26.5 21.5 48 48 48h352c26.5 0 48-21.5 48-48V112c0-26.5-21.5-48-48-48zm-6 400H54c-3.3 0-6-2.7-6-6V160h352v298c0 3.3-2.7 6-6 6z"></path></svg>
|
|||
|
|
<p style="font-size: 16px; line-height: 24px; margin: 0; padding-left: 5px;">
|
|||
|
|
October 18-20, 2022
|
|||
|
|
</p>
|
|||
|
|
</div>
|
|||
|
|
<div style="display: flex; align-items: center;">
|
|||
|
|
<svg style="enable-background: new 0 0 384 512; height: 14px;" viewbox="0 0 384 512" xmlns="http://www.w3.org/2000/svg">
|
|||
|
|
<path style="fill: #212121;" d="M192 0C85.9 0 0 86 0 192c0 71.1 24 93.3 151.3 297.4 18.8 30.1 62.7 30.1 81.5 0C360.1 285.2 384 263.1 384 192 384 85.9 298 0 192 0zm0 464C64.6 259.7 48 246.8 48 192c0-79.5 64.5-144 144-144s144 64.5 144 144c0 54.6-15.2 65.4-144 272zm-80-272c0-44.2 35.8-80 80-80s80 35.8 80 80-35.8 80-80 80-80-35.8-80-80z"></path></svg>
|
|||
|
|
<p style="font-size: 16px; line-height: 24px; margin: 0; padding-left: 5px;">
|
|||
|
|
Philadelphia, PA
|
|||
|
|
</p>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div>
|
|||
|
|
<a onclick="olytics.clickGo(this,'https://www.digitalpharmaeast.com/?utm_source=mediasites&utm_medium=internal&utm_campaign=articlead&utm_id=dpe22');" style="cursor:pointer;cursor: pointer; padding: 10px 40px; font-size: 16px; line-height: 22px; font-weight: 500; color: #ffffff; background-color: #ed2028;" class="button" target="_blank">Register</a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<p>
|
|||
|
|
“There’s a recognition; a familiarity with this type of [protein-based] vaccine technology that many are comfortable with, and would have had with HPV, shingles and flu shots,” Taylor said.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
“There is a segment of the population that are the so-called vaccine hesitant; they are the people we know are waiting for our vaccine. Never before have I seen a company and a product so closely followed, and that’s a big opportunity," Taylor said.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
"There are people who want to know they can have a new option; they want to know who is making that option," she added. "So, these two education campaigns are set up to really help people understand that.”
|
|||
|
|
</p>
|
|||
|
|
<div data-embed-button="node" data-entity-embed-display="view_mode:node.related_content" data-entity-type="node" data-entity-uuid="b9513585-1462-4bb6-bd66-5513a14a5a4b" data-langcode="en" class="embedded-entity">
|
|||
|
|
<div class="container-fluid p-0">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col">
|
|||
|
|
<h3 class="label">
|
|||
|
|
Related
|
|||
|
|
</h3>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col title font-weight-extra-bold">
|
|||
|
|
<a href="/pharma/jpm-2022-novavax-flags-triple-demand-for-covid-19-vaccine-pandemic-year-3" rel="bookmark"><span property="schema:name" class="field field--name-title field--type-string field--label-hidden">JPM 2022: How Novavax plans to be a COVID-19 vaccine force in 2022</span></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<p>
|
|||
|
|
She added that people are telling the company directly that access to Nuvaxovid “will convince them to get their vaccine. So that’s the first target audience for us.”
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
That group not only includes people getting their first shots but also those who may need boosters but put them off because of concerns about mRNA.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
And the choice goes both ways: Not only does Novavax want consumers to have a choice, they want to arm doctors with a different shot for their vaccine arsenal.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
Novavax is also targeting the pediatric population. There are questions about how well mRNA vaccines work in younger children. There are also safety concerns, notably the rates of myocarditis in young and adolescent boys, who appear to be more at risk from this condition, which can cause dangerous inflammation of the heart.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
Taylor believes Nuvaxovid can be a safe and efficacious second choice for children and adolescents outside of mRNA. “When you are talking to caregivers, there are certain considerations that are going to be front and center for them: So, tolerability and efficacy and the big question, how will it be tolerated by my child? That becomes very important, and that’s also the market we are starting to make inroads in," Taylor said.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
The education program route is one well-traveled by pharmas. In this case, it allows Novavax to talk up vaccines—and itself—without running afoul of rules against branded advertising. And awareness campaigns help prime the pump ahead of what could be branded DTC campaigns if and when the shot wins full FDA approval.
|
|||
|
|
</p>
|
|||
|
|
<div data-embed-button="node" data-entity-embed-display="view_mode:node.related_content" data-entity-type="node" data-entity-uuid="0f6ab279-b69b-4c81-9d31-bbd99378281e" data-langcode="en" class="embedded-entity">
|
|||
|
|
<div class="container-fluid p-0">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col">
|
|||
|
|
<h3 class="label">
|
|||
|
|
Related
|
|||
|
|
</h3>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col title font-weight-extra-bold">
|
|||
|
|
<a href="/marketing/pfizer-offers-a-soft-sell-a-strong-message-vaccines" rel="bookmark"><span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Pfizer offers a soft sell with a strong message on vaccines in first COVID ad</span></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<p>
|
|||
|
|
The "We Do Vaccines" program offers up educational information about common vaccine types and how they work, how vaccines are made and tested, and how Novavax believes its approach to technology makes its vaccines different.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
It has an <a href="https://www.wedovaccines.com/about-vaccines#how">accompanying website</a> that's a straightforward look at the different types of vaccine technologies and how they can help stop the spread of certain infectious diseases, from COVID to influenza. This particular campaign is aimed at consumers, Taylor said.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
Novavax’s name is on the website, though not prominently, and it doesn’t directly talk about the COVID shot. But the site does link to a <a href="https://www.wedovaccines.com/about-novavax">second site</a> that dives much more deeply into the protein technology Novavax uses for the COVID vaccine, approved with the brand name Nuvaxovid in Europe. (The name hasn’t been confirmed in the U.S. yet.)
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
The "Know Our Vax" program, meanwhile, targets doctors and other healthcare professionals with educational information about Novavax, its global approach and technology. This campaign's <a href="https://www.knowourvax.com/#vaccine-program">website</a> talks a little about Novavax itself and its history—and more about its vaccine tech and its pipeline, which includes work on other respiratory diseases. 
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
Both sites invite visitors to sign up for “vaccine updates” from the company. Novavax said it used an agency to create the campaigns, though it did not name which one.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
Pfizer and Moderna have both been relatively quiet on the marketing front. Neither want to talk to journalists about their marketing or education plans (at least this one). Marketing wasn't allowed while they were sold under emergency authorization, but now that they have full FDA approval, they can. Still, Pfizer has over the past four months been releasing a series of new DTC ads similar in tone to what Novavax is doing.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
In its first series of ads, which first aired late last year, <a href="https://www.fiercepharma.com/marketing/pfizer-biontech-select-comirnaty-as-brand-name-for-covid-19-vaccine">Pfizer</a> doesn’t mention the words “COVID-19” or “vaccine,” but rather takes the viewer to “the pursuit of normal” and features the deliciously mundane aspects of everyday life that vaccines have allowed to return.
|
|||
|
|
</p>
|
|||
|
|
<div data-embed-button="node" data-entity-embed-display="view_mode:node.related_content" data-entity-type="node" data-entity-uuid="e3809caf-199c-40c8-a3ea-10c1c77db700" data-langcode="en" class="embedded-entity">
|
|||
|
|
<div class="container-fluid p-0">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col">
|
|||
|
|
<h3 class="label">
|
|||
|
|
Related
|
|||
|
|
</h3>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col title font-weight-extra-bold">
|
|||
|
|
<a href="/marketing/say-what-you-see-novavax-taps-its-own-branding-for-latest-covid-vaccine" rel="bookmark"><span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Say what you see: Novavax taps its own branding for latest COVID vaccine</span></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<p>
|
|||
|
|
While nearing the finish line in the U.S., Novavax still has some way to go to actually cross it. First, the biopharma has been around 34 years now, but until last year, never saw a drug authorized or approved. As it nears a possible green light in its native U.S., that’s a lot of pressure for management to deliver.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
And it’s struggled to get here: Manufacturing issues have hampered delivery of its vaccine, with the company reportedly <a href="https://www.fiercepharma.com/manufacturing/novavax-struggling-to-make-covid-19-vax-to-meet-global-demand-report">struggling to meet quality standards</a>. It has since said it has cleared up any remaining issues with the FDA in a recent <a href="https://www.wsj.com/articles/novavaxs-covid-19-vaccine-moves-closer-to-fda-authorization-decision-11646562601" target="_blank">interview</a> with The Wall Street Journal.
|
|||
|
|
</p>
|
|||
|
|
<p>
|
|||
|
|
Novavax is also preparing for a full BLA filing in the second half of the year; should it win that approval, it can really hit the gas on its DTC plans. Taylor said Novavax isn’t thinking too far ahead in terms of marketing after an approval, saying they “are solely focused on delivering these new campaigns and our vaccine around the world.”
|
|||
|
|
</p>
|
|||
|
|
</div>
|
|||
|
|
</div><!----><!---->
|
|||
|
|
<div id="article-tags-bottom-row" class="row article-tags" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-12 my-4" data-v-0ba5eb0f="">
|
|||
|
|
<a href="/pharma" class="tag" data-v-0ba5eb0f="">Pharma</a><a href="/marketing" class="tag" data-v-0ba5eb0f="">Marketing</a><a href="/keyword/johnson-johnson" class="tag" data-v-0ba5eb0f="">Johnson & Johnson</a><a href="/keyword/astrazeneca" class="tag" data-v-0ba5eb0f="">AstraZeneca</a><a href="/keyword/biontech" class="tag" data-v-0ba5eb0f="">BioNTech</a><a href="/keyword/comirnaty" class="tag" data-v-0ba5eb0f="">Comirnaty</a><a href="/keyword/evusheld" class="tag" data-v-0ba5eb0f="">Evusheld</a><a href="/keyword/spikevax" class="tag" data-v-0ba5eb0f="">Spikevax</a><a href="/keyword/fda-advisory-committee" class="tag" data-v-0ba5eb0f="">FDA advisory committee</a><a href="/keyword/patient-education" class="tag" data-v-0ba5eb0f="">patient education</a><a href="/keyword/awareness-campaigns" class="tag" data-v-0ba5eb0f="">awareness campaigns</a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div id="article-body-finish" data-v-0ba5eb0f="" data-ga-read-media-recorded="1"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="content-sidebar col-lg-4 col-xl-3" data-v-0ba5eb0f="" style="margin-top: 4rem;">
|
|||
|
|
<!----><!----><!----><!---->
|
|||
|
|
<div class="block-quartz-ads">
|
|||
|
|
<div class="container p-0 ad-container">
|
|||
|
|
<div class="row justify-content-center ad-wrapper">
|
|||
|
|
<div id="sidebar-ad-wrapper" class="ad-placement-wrapper col d-flex justify-content-center sidebar-ad" style="min-width: 300px; min-height: 250px;">
|
|||
|
|
<div id="sidebar-ad" data-ad-slot="sidebar-ad" data-google-query-id="CJe8l8vdxvcCFT0B-QAdO0EOaQ">
|
|||
|
|
<div id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_4__container__" style="border: 0pt none;">
|
|||
|
|
<iframe id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_4" name="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_4" title="3rd party ad content" width="300" height="600" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" role="region" aria-label="Advertisement" tabindex="0" srcdoc="" data-google-container-id="7" style="border: 0px; vertical-align: bottom;" data-load-complete="true"></iframe>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col p-0">
|
|||
|
|
<div id="omeda-promo-right-rail-after-1st-ad"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="container-fluid p-0">
|
|||
|
|
<div class="row omeda-newsletter-block">
|
|||
|
|
<div class="col p-0">
|
|||
|
|
<!---->
|
|||
|
|
<div class="row text-left medium-stripe-pattern" style="width: 300px; margin: auto;">
|
|||
|
|
<div class="col p-0">
|
|||
|
|
<span class="component-title__ small text-uppercase">Our <span class="brand-1">Newsletter</span></span>
|
|||
|
|
<div class="stripe-pattern"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col p-0" style="">
|
|||
|
|
<iframe id="FiercePharma_short" src="https://sample.dragonforms.com/FiercePharma_short" height="430" width="300" style="border:0" name="FiercePharma_short"></iframe>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="container p-0 ad-container" style="margin-bottom: 1.5rem;">
|
|||
|
|
<div class="row justify-content-center ad-wrapper">
|
|||
|
|
<div id="sidebar-ad2-wrapper" class="ad-placement-wrapper col d-flex justify-content-center sidebar-ad2" style="min-width: 300px; min-height: 250px;">
|
|||
|
|
<div id="sidebar-ad2" data-ad-slot="sidebar-ad2" data-google-query-id="CJi8l8vdxvcCFT0B-QAdO0EOaQ">
|
|||
|
|
<div id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_5__container__" style="border: 0pt none;">
|
|||
|
|
<iframe id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_5" name="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_5" title="3rd party ad content" width="300" height="600" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" role="region" aria-label="Advertisement" tabindex="0" srcdoc="" style="border: 0px; vertical-align: bottom;" data-google-container-id="8" data-load-complete="true"></iframe>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row float-sidebar-ad">
|
|||
|
|
<div class="container p-0 ad-container" style="margin-bottom: 1.5rem;">
|
|||
|
|
<div class="row justify-content-center ad-wrapper">
|
|||
|
|
<div id="sidebar-ad3-wrapper" class="ad-placement-wrapper col d-flex justify-content-center sidebar-ad3" style="min-width: 300px; min-height: 250px;">
|
|||
|
|
<div id="sidebar-ad3" data-ad-slot="sidebar-ad3" data-google-query-id="CJm8l8vdxvcCFT0B-QAdO0EOaQ">
|
|||
|
|
<div id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_6__container__" style="border: 0pt none;">
|
|||
|
|
<iframe id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_6" name="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_6" title="3rd party ad content" width="300" height="600" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" role="region" aria-label="Advertisement" tabindex="0" srcdoc="" style="border: 0px; vertical-align: bottom;" data-google-container-id="9" data-load-complete="true"></iframe>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="container" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row recommended-content" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-12" data-v-0ba5eb0f="">
|
|||
|
|
<!---->
|
|||
|
|
<div class="row" show-date="false">
|
|||
|
|
<div class="col-lg-11 offset-lg-1 pl-lg-0">
|
|||
|
|
<div class="row mb-5">
|
|||
|
|
<div class="col pl-sm-0">
|
|||
|
|
<h3 class="component-title__ large">
|
|||
|
|
Related <span class="brand-1">Articles</span>
|
|||
|
|
</h3>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row element-bg alt pt-4 py-lg-4">
|
|||
|
|
<div class="col-md-6 col-lg-3 mb-3 mb-lg-0">
|
|||
|
|
<article class="small-article mb-4 mb-lg-0 d-flex align-items-center flex-lg-column">
|
|||
|
|
<div class="col-4 col-lg-12 p-0 px-lg-4 mb-lg-3 media">
|
|||
|
|
<a href="https://www.fiercepharma.com/pharma/fda-rebukes-pfizers-suggestion-take-more-paxlovid-if-covid-19-symptoms-return?itm_source=parsely-api" title="FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return">
|
|||
|
|
<figure class="image-wrapper" data-v-2243ef14="">
|
|||
|
|
<img data-url="https://qtxasset.com/cdn-cgi/image/w=250,h=165,g=0.5x0.5,f=auto,fit=crop/https://qtxasset.com/quartz/qcloud5/media/image/fiercehealthcare/1620661895/GettyImages-1254047772.jpg/GettyImages-1254047772.jpg?VersionId=KT0g0zyRI6oZTZrtcepL3Qg9zZ6MprLW" alt="" height="165" class="img-fluid rounded not-loaded" data-v-2243ef14="" src="https://qtxasset.com/cdn-cgi/image/w=250,h=165,g=0.5x0.5,f=auto,fit=crop/https://qtxasset.com/quartz/qcloud5/media/image/fiercehealthcare/1620661895/GettyImages-1254047772.jpg/GettyImages-1254047772.jpg?VersionId=KT0g0zyRI6oZTZrtcepL3Qg9zZ6MprLW" />
|
|||
|
|
</figure></a>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-8 col-lg-12 content" style="min-height: 98px;">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="element-title xsmall">
|
|||
|
|
<a href="https://www.fiercepharma.com/pharma/fda-rebukes-pfizers-suggestion-take-more-paxlovid-if-covid-19-symptoms-return?itm_source=parsely-api" title="FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return">FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return</a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row mt-3">
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="byline small">
|
|||
|
|
<span class="date">May 4, 2022 03:23pm</span>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</article>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-md-6 col-lg-3 mb-3 mb-lg-0">
|
|||
|
|
<article class="small-article mb-4 mb-lg-0 d-flex align-items-center flex-lg-column">
|
|||
|
|
<div class="col-4 col-lg-12 p-0 px-lg-4 mb-lg-3 media">
|
|||
|
|
<a href="https://www.fiercepharma.com/marketing/takeda-spinout-phathom-clinches-fda-twin-nods-gi-infection-combos-plus-timely-capital?itm_source=parsely-api" title="Takeda spinout Phathom clinches FDA twin nods for GI infection combos—plus timely capital infusion">
|
|||
|
|
<figure class="image-wrapper" data-v-2243ef14="">
|
|||
|
|
<img data-url="https://qtxasset.com/cdn-cgi/image/w=250,h=165,g=0.5x0.5,f=auto,fit=crop/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1621440927/Stomach.jpg?VersionId=Yul7G5nsUkEK8hWaGFY4M6fA0HIIvqrX" alt="" height="165" class="img-fluid rounded not-loaded" data-v-2243ef14="" src="https://qtxasset.com/cdn-cgi/image/w=250,h=165,g=0.5x0.5,f=auto,fit=crop/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1621440927/Stomach.jpg?VersionId=Yul7G5nsUkEK8hWaGFY4M6fA0HIIvqrX" />
|
|||
|
|
</figure></a>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-8 col-lg-12 content" style="min-height: 98px;">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="element-title xsmall">
|
|||
|
|
<a href="https://www.fiercepharma.com/marketing/takeda-spinout-phathom-clinches-fda-twin-nods-gi-infection-combos-plus-timely-capital?itm_source=parsely-api" title="Takeda spinout Phathom clinches FDA twin nods for GI infection combos—plus timely capital infusion">Takeda spinout Phathom clinches FDA twin nods for GI infection combos—plus timely capital infusion</a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row mt-3">
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="byline small">
|
|||
|
|
<span class="date">May 4, 2022 11:12am</span>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</article>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-md-6 col-lg-3 mb-3 mb-lg-0">
|
|||
|
|
<article class="small-article mb-4 mb-lg-0 d-flex align-items-center flex-lg-column">
|
|||
|
|
<div class="col-4 col-lg-12 p-0 px-lg-4 mb-lg-3 media">
|
|||
|
|
<a href="https://www.fiercepharma.com/pharma/regeneron-ceo-points-eylea-known-entity-company-tries-fend-competition-roches-vabysmo?itm_source=parsely-api" title="Regeneron counts on Eylea's track record to fend off Roche rival Vabysmo">
|
|||
|
|
<figure class="image-wrapper" data-v-2243ef14="">
|
|||
|
|
<img data-url="https://qtxasset.com/cdn-cgi/image/w=250,h=165,g=0.5x0.5,f=auto,fit=crop/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1624411860/Eylea.jpg/Eylea.jpg?VersionId=.bkQlxFGCtIKq2VK_Iq2Rgh5gRE5yduL" alt="" height="165" class="img-fluid rounded not-loaded" data-v-2243ef14="" src="https://qtxasset.com/cdn-cgi/image/w=250,h=165,g=0.5x0.5,f=auto,fit=crop/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1624411860/Eylea.jpg/Eylea.jpg?VersionId=.bkQlxFGCtIKq2VK_Iq2Rgh5gRE5yduL" />
|
|||
|
|
</figure></a>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-8 col-lg-12 content" style="min-height: 98px;">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="element-title xsmall">
|
|||
|
|
<a href="https://www.fiercepharma.com/pharma/regeneron-ceo-points-eylea-known-entity-company-tries-fend-competition-roches-vabysmo?itm_source=parsely-api" title="Regeneron counts on Eylea's track record to fend off Roche rival Vabysmo">Regeneron counts on Eylea's track record to fend off Roche rival Vabysmo</a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row mt-3">
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="byline small">
|
|||
|
|
<span class="date">May 4, 2022 11:05am</span>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</article>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-md-6 col-lg-3 mb-3 mb-lg-0">
|
|||
|
|
<article class="small-article mb-4 mb-lg-0 d-flex align-items-center flex-lg-column">
|
|||
|
|
<div class="col-4 col-lg-12 p-0 px-lg-4 mb-lg-3 media">
|
|||
|
|
<a href="https://www.fiercepharma.com/pharma/moderna-tunes-booster-pitch-ahead-potential-shift-endemic-covid-19-market-fall?itm_source=parsely-api" title="Moderna tunes booster pitch ahead of potential shift to private COVID vaccine market this fall">
|
|||
|
|
<figure class="image-wrapper" data-v-2243ef14="">
|
|||
|
|
<img data-url="https://qtxasset.com/cdn-cgi/image/w=250,h=165,g=0.5x0.5,f=auto,fit=crop/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1635799225/Moderna%20Norwood%20plant.jpg/Moderna%20Norwood%20plant.jpg?VersionId=JjDUfOX.viF18JFRog72nKo6ivUyn_xI" alt="" height="165" class="img-fluid rounded not-loaded" data-v-2243ef14="" src="https://qtxasset.com/cdn-cgi/image/w=250,h=165,g=0.5x0.5,f=auto,fit=crop/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1635799225/Moderna%20Norwood%20plant.jpg/Moderna%20Norwood%20plant.jpg?VersionId=JjDUfOX.viF18JFRog72nKo6ivUyn_xI" />
|
|||
|
|
</figure></a>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-8 col-lg-12 content" style="min-height: 98px;">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="element-title xsmall">
|
|||
|
|
<a href="https://www.fiercepharma.com/pharma/moderna-tunes-booster-pitch-ahead-potential-shift-endemic-covid-19-market-fall?itm_source=parsely-api" title="Moderna tunes booster pitch ahead of potential shift to private COVID vaccine market this fall">Moderna tunes booster pitch ahead of potential shift to private COVID vaccine market this fall</a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="row mt-3">
|
|||
|
|
<div class="col">
|
|||
|
|
<div class="byline small">
|
|||
|
|
<span class="date">May 4, 2022 10:55am</span>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</article>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="layout layout--onecol container-fluid p-0 full-width-col">
|
|||
|
|
<div class="layout__region layout__region--content">
|
|||
|
|
<div class="block block-quartz-apifirst block-quartz-apifirst-node-infinite-scroll"></div>
|
|||
|
|
<div class="container-fluid" style="">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="container-fluid p-0 content-infinite-scroll-page" data-v-d5c4e7e8="">
|
|||
|
|
<div class="container-fluid p-0" data-v-d5c4e7e8="">
|
|||
|
|
<a name="inf-f95094da-693d-4fd6-ad1c-44c78ebb1444" data-v-d5c4e7e8="" id="inf-f95094da-693d-4fd6-ad1c-44c78ebb1444"></a>
|
|||
|
|
<div id="article-container" class="container-fluid p-0" data-v-0ba5eb0f="" data-v-d5c4e7e8="">
|
|||
|
|
<!---->
|
|||
|
|
<div class="container-fluid p-0 element-bg gradient position-relative dark" data-v-0ba5eb0f="" style="min-height: 362px;">
|
|||
|
|
<img src="https://www.fiercepharma.com/themes/custom/quartz_barrio/images/brand/Fierce-Brand-Element.svg" /><!---->
|
|||
|
|
</div>
|
|||
|
|
<div class="container" data-v-0ba5eb0f="" style="min-height: 250px;">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-8 col-xl-9" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-11 offset-lg-1" data-v-0ba5eb0f="">
|
|||
|
|
<!----><!----><!----><!---->
|
|||
|
|
<div id="article-tags-bottom-row" class="row article-tags" data-v-0ba5eb0f="">
|
|||
|
|
<!---->
|
|||
|
|
</div>
|
|||
|
|
<div id="article-body-finish" data-v-0ba5eb0f="" data-ga-read-media-recorded="1"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="content-sidebar col-lg-4 col-xl-3" data-v-0ba5eb0f="" style="margin-top: 4rem;">
|
|||
|
|
<!----><!----><!----><!----><!----><!----><!----><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="container" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row recommended-content" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-12" data-v-0ba5eb0f="">
|
|||
|
|
<!----><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div><!---->
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="container-fluid p-0 content-infinite-scroll-page" data-v-d5c4e7e8="">
|
|||
|
|
<div class="container-fluid p-0" data-v-d5c4e7e8="">
|
|||
|
|
<a name="inf-978daefc-c789-4ef0-9061-6f80b47f9e05" data-v-d5c4e7e8="" id="inf-978daefc-c789-4ef0-9061-6f80b47f9e05"></a>
|
|||
|
|
<div id="article-container" class="container-fluid p-0" data-v-0ba5eb0f="" data-v-d5c4e7e8="">
|
|||
|
|
<!---->
|
|||
|
|
<div class="container-fluid p-0 element-bg gradient position-relative dark" data-v-0ba5eb0f="" style="min-height: 362px;">
|
|||
|
|
<img src="https://www.fiercepharma.com/themes/custom/quartz_barrio/images/brand/Fierce-Brand-Element.svg" /><!---->
|
|||
|
|
</div>
|
|||
|
|
<div class="container" data-v-0ba5eb0f="" style="min-height: 250px;">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-8 col-xl-9" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-11 offset-lg-1" data-v-0ba5eb0f="">
|
|||
|
|
<!----><!----><!----><!---->
|
|||
|
|
<div id="article-tags-bottom-row" class="row article-tags" data-v-0ba5eb0f="">
|
|||
|
|
<!---->
|
|||
|
|
</div>
|
|||
|
|
<div id="article-body-finish" data-v-0ba5eb0f="" data-ga-read-media-recorded="1"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="content-sidebar col-lg-4 col-xl-3" data-v-0ba5eb0f="" style="margin-top: 4rem;">
|
|||
|
|
<!---->
|
|||
|
|
<div class="row">
|
|||
|
|
<!---->
|
|||
|
|
</div><!----><!----><!----><!----><!----><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="container" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row recommended-content" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-12" data-v-0ba5eb0f="">
|
|||
|
|
<!----><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div><!---->
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="container-fluid p-0 content-infinite-scroll-page" data-v-d5c4e7e8="">
|
|||
|
|
<div class="container-fluid p-0" data-v-d5c4e7e8="">
|
|||
|
|
<a name="inf-2d6e1ea2-0622-46c0-9abb-974b1cf53dd9" data-v-d5c4e7e8="" id="inf-2d6e1ea2-0622-46c0-9abb-974b1cf53dd9"></a>
|
|||
|
|
<div id="article-container" class="container-fluid p-0" data-v-0ba5eb0f="" data-v-d5c4e7e8="">
|
|||
|
|
<!---->
|
|||
|
|
<div class="container-fluid p-0 element-bg gradient position-relative dark" data-v-0ba5eb0f="" style="min-height: 362px;">
|
|||
|
|
<img src="https://www.fiercepharma.com/themes/custom/quartz_barrio/images/brand/Fierce-Brand-Element.svg" /><!---->
|
|||
|
|
</div>
|
|||
|
|
<div class="container" data-v-0ba5eb0f="" style="min-height: 250px;">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-8 col-xl-9" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-lg-11 offset-lg-1" data-v-0ba5eb0f="">
|
|||
|
|
<!----><!----><!----><!---->
|
|||
|
|
<div id="article-tags-bottom-row" class="row article-tags" data-v-0ba5eb0f="">
|
|||
|
|
<!---->
|
|||
|
|
</div>
|
|||
|
|
<div id="article-body-finish" data-v-0ba5eb0f="" data-ga-read-media-recorded="1"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="content-sidebar col-lg-4 col-xl-3" data-v-0ba5eb0f="" style="margin-top: 4rem;">
|
|||
|
|
<!----><!---->
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col p-0">
|
|||
|
|
<div class="marketing-promotion"></div>
|
|||
|
|
</div>
|
|||
|
|
</div><!----><!----><!----><!----><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="container" data-v-0ba5eb0f="">
|
|||
|
|
<div class="row recommended-content" data-v-0ba5eb0f="">
|
|||
|
|
<div class="col-12" data-v-0ba5eb0f="">
|
|||
|
|
<!----><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div><!----><!---->
|
|||
|
|
</div>
|
|||
|
|
</div><!---->
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="container-fluid p-0 content-infinite-scroll-page" data-v-d5c4e7e8="">
|
|||
|
|
<!---->
|
|||
|
|
</div><!---->
|
|||
|
|
</div>
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="container-fluid p-0 content-infinite-scroll-page" data-v-d5c4e7e8="">
|
|||
|
|
<!---->
|
|||
|
|
</div><!---->
|
|||
|
|
</div>
|
|||
|
|
<div class="row more-content-button my-5">
|
|||
|
|
<div class="col-12 text-center">
|
|||
|
|
<a class="extended-load d-inline-block"><span class="d-block">See more articles</span><span class="d-block icon"><svg aria-hidden="true" focusable="false" data-prefix="fal" data-icon="chevron-circle-down" class="svg-inline--fa fa-chevron-circle-down fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 512 512">
|
|||
|
|
<path fill="currentColor" d="M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm216 248c0 118.7-96.1 216-216 216-118.7 0-216-96.1-216-216 0-118.7 96.1-216 216-216 118.7 0 216 96.1 216 216zm-207.5 86.6l115-115.1c4.7-4.7 4.7-12.3 0-17l-7.1-7.1c-4.7-4.7-12.3-4.7-17 0L256 303l-99.5-99.5c-4.7-4.7-12.3-4.7-17 0l-7.1 7.1c-4.7 4.7-4.7 12.3 0 17l115 115.1c4.8 4.6 12.4 4.6 17.1-.1z"></path></svg></span></a>
|
|||
|
|
</div><!---->
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="layout layout--onecol container-fluid p-0 full-width-col">
|
|||
|
|
<div class="layout__region layout__region--content">
|
|||
|
|
<div class="block block-quartz-blocks block-quartz-blocks-footer footer-wrapper gray-bg">
|
|||
|
|
<footer>
|
|||
|
|
<div class="footer-top container">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col-md-4 col-lg-5 logo-social mb-4 mb-md-0">
|
|||
|
|
<div class="logo" style="min-height: 40px; min-width: 100px;">
|
|||
|
|
<a href="/" rel="home"><img src="https://qtxasset.com/quartz/qcloud5/FP21%20Logo.svg" alt="Home" style="min-height: 40px;" /></a>
|
|||
|
|
</div>
|
|||
|
|
<div class="social">
|
|||
|
|
<a class="linkedin" href="https://www.linkedin.com/showcase/fierce-pharma/" aria-label="LinkedIn" target="_blank"><svg aria-hidden="true" focusable="false" data-prefix="fab" data-icon="linkedin-in" class="svg-inline--fa fa-linkedin-in fa-w-14" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 448 512">
|
|||
|
|
<path fill="currentColor" d="M100.28 448H7.4V148.9h92.88zM53.79 108.1C24.09 108.1 0 83.5 0 53.8a53.79 53.79 0 0 1 107.58 0c0 29.7-24.1 54.3-53.79 54.3zM447.9 448h-92.68V302.4c0-34.7-.7-79.2-48.29-79.2-48.29 0-55.69 37.7-55.69 76.7V448h-92.78V148.9h89.08v40.8h1.3c12.4-23.5 42.69-48.3 87.88-48.3 94 0 111.28 61.9 111.28 142.3V448z"></path></svg></a><a class="twitter" href="https://twitter.com/fiercepharma" aria-label="Twitter" target="_blank"><svg aria-hidden="true" focusable="false" data-prefix="fab" data-icon="twitter" class="svg-inline--fa fa-twitter fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewbox="0 0 512 512">
|
|||
|
|
<path fill="currentColor" d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"></path></svg></a>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-md-8 col-lg-7 footer-menu">
|
|||
|
|
<ul class="clearfix nav">
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<span class="nav-link nav-link-">Connect</span>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/fiercepharmacom/about-us" title="The Team" class="nav-link nav-link--fiercepharmacom-about-us" data-drupal-link-system-path="node/6671">The Team</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/fiercepharmacom/advertise" title="Advertise" class="nav-link nav-link--fiercepharmacom-advertise" data-drupal-link-system-path="node/6676">Advertise</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<span class="nav-link nav-link-">Join Us</span>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://fiercepharma.questexinfo.com/loading.do?omedasite=Pharma_full" class="nav-link nav-link-https--fiercepharmaquestexinfocom-loadingdoomedasitepharma-full">Newsletters</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/resources" title="Resources" class="nav-link nav-link--resources" data-drupal-link-system-path="node/31">Resources</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="/fiercepharmacom/rss-feeds" title="RSS Feeds" class="nav-link nav-link--fiercepharmacom-rss-feeds" data-drupal-link-system-path="node/6681">RSS Feeds</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<span class="nav-link nav-link-">Our Brands</span>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercebiotech.com/" class="nav-link nav-link-https--wwwfiercebiotechcom-">Fierce Biotech</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercehealthcare.com/" class="nav-link nav-link-https--wwwfiercehealthcarecom-">Fierce Healthcare</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercepharma.com/" class="nav-link nav-link-https--wwwfiercepharmacom-">Fierce Pharma</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</li>
|
|||
|
|
<li class="nav-item menu-item--expanded">
|
|||
|
|
<span class="nav-link nav-link-">Our Events</span>
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="nav-item">
|
|||
|
|
<a href="https://www.fiercelifesciences.com/" title="Life Sciences Events" class="nav-link nav-link-https--wwwfiercelifesciencescom-">Life Sciences Events</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<div class="footer-bottom">
|
|||
|
|
<div class="container">
|
|||
|
|
<div class="row">
|
|||
|
|
<div class="col-md-4 col-lg-5 mb-3 mb-md-0 questex-logo">
|
|||
|
|
<a target="”_blank”" href="https://questex.com/"><svg width="160px" height="37px" xmlns="https://www.w3.org/2000/svg" viewbox="0 0 834.3 171.7">
|
|||
|
|
<g fill="#231f20">
|
|||
|
|
<path d="M328.4 116.4c.8 10.8 4 20.4 10.8 28.6 7.6 9.2 17.4 14.7 29.2 16 18 1.9 33.5-3.6 46-16.9l1.2-1.5c.6-.8 1.3-.8 2-.2 2 1.6 4 3.3 5.9 4.9.8.7.4 1.4-.1 2-2.7 2.8-5.2 5.8-8.1 8.3-8.1 6.8-17.7 10.8-28 12.8-12.3 2.3-24.4 1.5-36-3.5-17.5-7.6-28.4-20.8-32.6-39.3-3.3-14.6-2-28.9 4.5-42.5 8.1-16.9 21.5-27.1 40-30.2 11.2-1.9 22.1-.7 32.4 4.1 7.3 3.4 13.2 8.4 18.2 14.7 6.5 8.1 10.6 17.2 12.3 27.4.8 4.6 1.2 9.2.7 13.9-.1 1.2-.5 1.6-1.7 1.6h-96.7zm.4-10.4h86.8c-.9-11.5-5.3-21.4-13-29.8-7.4-8-16.8-11.7-27.5-12.1-29-1-45.1 20-46.3 41.9M627 116.4c.2 4.4.9 8.5 2.1 12.4 5 15.7 15.2 26.2 31.2 30.8 11.6 3.3 23 2 34-2.5 7.7-3.2 14.5-7.8 19.7-14.4.8-1 1.4-1 2.4-.2 1.8 1.5 3.5 3 5.3 4.4 1 .8 1 1.5.3 2.5-2.7 3.5-5.8 6.7-9.4 9.3-9.2 6.9-19.5 10.9-30.8 12.3-14.8 1.9-28.7-.9-41.2-9.2-12.3-8.2-20-19.7-23.2-34-3.3-14.8-2.1-29.2 4.5-43 7.7-16 20.4-26.1 37.9-29.7 11.9-2.4 23.5-1.4 34.6 3.8 7.2 3.3 13.1 8.4 18.1 14.6 6.5 8.1 10.6 17.3 12.3 27.5.8 4.5 1.2 9.1.7 13.7-.1 1.2-.5 1.6-1.8 1.6H627zm87.1-10.3v-.8c-.5-5.3-1.7-10.4-3.9-15.2-3.5-7.8-8.4-14.6-15.7-19.4-5.8-3.9-12.3-5.8-19.3-6.3-8.8-.7-17.2.7-25.1 4.8-11.5 6-18.3 15.7-21.5 28-.7 2.9-1.1 5.8-1.7 8.9h87.2zM196.9 56.8h11.2v68.3c0 5.4.6 10.6 2.6 15.7 4.9 12.1 13.8 18.9 26.7 20.5 8.2 1 16-.2 23.4-4 9.9-5.2 15.5-13.6 17.6-24.4.6-3 .8-6.1.8-9.1.1-21.8 0-43.5 0-65.3v-1.6h11.1v112H280v-17.7c-1.3 1.8-2.3 3.3-3.5 4.7-6.3 7.7-14.4 12.5-24.1 14.6-10 2.2-20 1.9-29.6-2.1-13.1-5.4-21-15.3-24.3-28.9-1-4.2-1.5-8.6-1.6-12.9-.1-22.8-.1-45.7-.1-68.5v-1.3zM783.9 104.5c2-2.6 4-5.2 5.9-7.7l30.3-39.3c.3-.4 1-.7 1.6-.7 3-.1 6-.1 9 0 .5 0 1.2.3 1.4.7.2.2-.1 1-.4 1.4-13.7 17.6-27.5 35.2-41.2 52.8-.1.1-.2.3-.4.5l44.1 55.5c-.2.9-.8 1.2-1.7 1.2-3.1-.1-6.3-.1-9.4 0-.9 0-1.4-.3-1.9-1-12.7-15.8-25.3-31.6-38-47.4-.1-.2-.3-.3-.5-.6-2.2 2.8-4.4 5.6-6.5 8.4-10.2 13.2-20.4 26.4-30.6 39.5-.5.7-1 1-1.9 1-3-.1-6 0-9 0-.5 0-1.3-.2-1.4-.5-.1-.4.1-1.1.4-1.5 9.6-12.3 19.3-24.5 28.9-36.8 4.5-5.7 8.9-11.4 13.4-17 .6-.7.5-1.2 0-1.9-13.5-17.4-27-34.9-40.4-52.3-.3-.4-.6-1.1-.5-1.6.1-.3 1-.5 1.5-.5h9.4c.8 0 1.2.2 1.7.8 11.7 15.2 23.4 30.4 35.1 45.7.4.4.7.8 1.1 1.3M483.6 171.7c-11.6-.1-22.2-3.3-31.4-10.5-3.5-2.8-6.5-6-9.1-9.6-.7-1-.6-1.6.4-2.4 1.9-1.4 3.7-2.8 5.5-4.2 1.2-.9 1.6-.8 2.4.4 6 8.8 14.3 13.9 24.7 15.5 7.6 1.2 15.1.7 22.2-2.4 6.2-2.7 10.7-6.9 12.1-13.7 1.7-8.4-1.3-15.1-8.1-20.2-5.3-4-11.3-6.5-17.3-8.9-6.6-2.7-13.3-5.1-19.5-8.7-4.5-2.6-8.6-5.7-11.6-10.1-5.9-8.6-5.4-21.2 1.1-29.9 4.9-6.5 11.7-10.2 19.5-11.9 11.4-2.5 22.4-1.1 32.6 4.8 5.1 3 9.4 6.9 12.8 11.8.7 1 .6 1.7-.4 2.5-1.8 1.3-3.6 2.8-5.4 4.2-.9.7-1.5.7-2.2-.3-5.7-7.7-13.2-12.3-22.6-13.6-7.3-1-14.4-.2-20.6 4-9.6 6.5-10 19.5-.9 26.8 5 4 10.8 6.3 16.5 8.8 6.3 2.7 12.7 5.3 18.9 8.4 5.8 2.8 10.9 6.7 14.6 12.2 3.7 5.7 5 12 4.4 18.7-1.4 14.1-10.1 21.9-22.8 26-2.2.7-4.4 1.2-6.6 1.5-3.3.4-6.2.6-9.2.8M554.7 66.4h-19.6v-9.7h19.6V21.8c1.6-.2 3-.4 4.5-.7 1.6-.2 3.1-.4 4.7-.6 1.5-.2 1.8.2 1.8 1.7v34.4h36.2v9.7h-36.2c0 .5-.1.8-.1 1.1V139c0 4.9.9 9.6 3.5 13.9 2.8 4.6 7 7.1 12.2 8 5.5.9 11 .5 16-2.2 1.2-.6 2.2-1.4 3.3-2.2.9-.7 1.5-.6 2.1.4 1 1.8 1.9 3.7 3 5.6.7 1.2.2 1.9-.7 2.6-3.7 2.8-7.7 4.8-12.3 5.6-8.5 1.6-16.7 1-24.3-3.5-7-4-10.9-10.4-12.5-18.1-.8-3.9-1.2-7.9-1.3-11.9-.1-23.1-.1-46.1-.1-69.2v-1.6zM145.3 24.9C112-8.3 58.1-8.3 24.9 24.9s-33.2 87.1 0 120.3C40 160.4 59.4 168.6 79.2 170v.2h91v-91h-.2c-1.4-19.8-9.6-39.2-24.7-54.3m-6.5 113.6c-29.6 29.6-77.6 29.6-107.2 0C2 108.9 2 60.9 31.6 31.3c29.6-29.6 77.6-29.6 107.2 0 29.6 29.6 29.6 77.6 0 107.2"></path>
|
|||
|
|
<path d="M132.3 131.8c-25.9 25.9-68 25.9-93.8 0-25.9-25.9-25.9-68 0-93.8 25.9-25.9 68-25.9 93.8 0 25.9 25.8 25.9 67.9 0 93.8M41.1 40.6c-24.4 24.4-24.4 64.1 0 88.5 24.4 24.4 64.1 24.4 88.5 0 24.4-24.4 24.4-64.1 0-88.5-24.4-24.4-64.1-24.4-88.5 0"></path>
|
|||
|
|
</g></svg></a>
|
|||
|
|
</div>
|
|||
|
|
<div class="col-md-8 col-lg-7 copy">
|
|||
|
|
<div class="row justify-content-md-end">
|
|||
|
|
<div class="col">
|
|||
|
|
<ul class="menu">
|
|||
|
|
<li class="">©2022 Questex LLC All rights reserved.
|
|||
|
|
</li>
|
|||
|
|
<li class="font-weight-medium">
|
|||
|
|
<a href="https://questex.com/terms-and-conditions/">Terms of use</a>
|
|||
|
|
</li>
|
|||
|
|
<li class="font-weight-medium">
|
|||
|
|
<a href="https://questex.com/privacy-policy/">Privacy Policy</a>
|
|||
|
|
</li>
|
|||
|
|
</ul>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</footer>
|
|||
|
|
</div>
|
|||
|
|
<div class="block block-quartz-ads">
|
|||
|
|
<div class="container p-0 ad-container">
|
|||
|
|
<div class="row justify-content-center ad-wrapper">
|
|||
|
|
<div id="bottom-sticky-wrapper" class="ad-placement-wrapper col d-flex justify-content-center bottom-sticky">
|
|||
|
|
<div id="bottom-sticky" data-ad-slot="bottom-sticky" data-google-query-id="CKvPncrdxvcCFbXgWwod9IQKIQ" style="display: none;">
|
|||
|
|
<div id="google_ads_iframe_/298443/questex.lifesciences/fiercepharma/marketing_7__container__" style="border: 0pt none;"></div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</article>
|
|||
|
|
</section>
|
|||
|
|
</main>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
</div>
|
|||
|
|
<script src="/themes/custom/quartz_barrio/js/global.js?v=3" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/runtime.js?v=98c7521aa7bcb40e" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/vendor-runtime-core.esm-bundler.js?v=98c7521aa7bcb40e" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/vendor-compiler-core.esm-bundler.js?v=98c7521aa7bcb40e" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/vendor-runtime-dom.esm-bundler.js?v=98c7521aa7bcb40e" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/vendor-vue-social-sharing.js?v=7c3a" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/nodearticle-46826cd4.js?v=b208f98076077f6c1b57bfab" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/nodearticle-80f4f91d.js?v=b208f98076077f6c1b57bfab" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/nodearticle-8b39a80f.js?v=b208f98076077f6c1b57bfab" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/nodearticle-cdd60c62.js?v=b208f98076077f6c1b57bfab" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/nodearticle-d0741da4.js?v=b208f98076077f6c1b57bfab" async="async"></script>
|
|||
|
|
<script src="/modules/custom/quartz_apifirst/compiled/nodearticle-e209b0d1.js?v=b208f98076077f6c1b57bfab" async="async"></script>
|
|||
|
|
<script src="/sites/qcloud5/files/js/js_IPqtJUOMQwbiuMhUgEiptzZLuDhzNidZI6DfnFT7qqA.js"></script>
|
|||
|
|
<script src="/themes/custom/quartz_barrio/js/searchmodal.js?v=1.4" async="async"></script>
|
|||
|
|
<link rel="stylesheet" media="all" href="/sites/qcloud5/files/css/css_oVz8udtXB7T-TOfUgHcTFoOMCti64Yf498kmWJ277BA.css" />
|
|||
|
|
<link rel="stylesheet" media="all" href="/sites/qcloud5/files/css/css_hJ238ZnN8hXVuT8y5Lnl9aaSXnhuVGEmI-zqELNRdpQ.css" />
|
|||
|
|
<script type="text/javascript">
|
|||
|
|
//<![CDATA[
|
|||
|
|
window.NREUM||(NREUM={});NREUM.info={"beacon":"bam-cell.nr-data.net","licenseKey":"44925d6b58","applicationID":"390221574","transactionName":"NFBaMhZVDRIHABUPCg0aeQUQXQwPSScTExUCWWQIC1AGPSUMDxIXDFlUAxZoLQ4CBjcPABR2VwgQRgwNCgYTS1sVXF0R","queueTime":0,"applicationTime":1378,"atts":"GBdZRF5PHhw=","errorBeacon":"bam-cell.nr-data.net","agent":""}
|
|||
|
|
//]]>
|
|||
|
|
</script>
|
|||
|
|
<script type="text/javascript" id="">
|
|||
|
|
//<![CDATA[
|
|||
|
|
(function(){var a=document,b=a.getElementsByTagName("head")[0];a=a.createElement("script");var c="https:"==document.location.protocol?"https://":"http://";a.type="text/javascript";a.async=!0;a.src=c+"s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js";b.appendChild(a)})();
|
|||
|
|
//]]>
|
|||
|
|
</script>
|
|||
|
|
<script type="text/javascript" id="">
|
|||
|
|
//<![CDATA[
|
|||
|
|
(function(){var a=document.createElement("script");a.type="text/javascript";a.async=!0;a.src="https://ws.zoominfo.com/pixel/WgRbL7NLS90BFPSb6pBa";var b=document.getElementsByTagName("script")[0];b.parentNode.insertBefore(a,b)})();
|
|||
|
|
//]]>
|
|||
|
|
</script> <noscript><img src="https://ws.zoominfo.com/pixel/WgRbL7NLS90BFPSb6pBa" width="1" height="1" style="display: none;" /></noscript>
|
|||
|
|
<script type="text/javascript" id="">
|
|||
|
|
//<![CDATA[
|
|||
|
|
window.bid=window.bid||"6678I9124356A5P";window.oid=window.oid||"5d6cdb41c83d4fb0a6a384e42aa46df6";window.olytics||(window.olytics=[]);window.olytics.methods=["fire","confirm"];window.olytics.factory=function(b){return function(){var a=Array.prototype.slice.call(arguments);return a.unshift(b),window.olytics.push(a),window.olytics}};for(var i=0;i<window.olytics.methods.length;i++){var method=window.olytics.methods[i];window.olytics[method]=window.olytics.factory(method)}
|
|||
|
|
olytics.load=function(b){if(!document.getElementById("olyticsImport")){window.a=window.olytics;var a=document.createElement("script");a.async=!0;a.id="olyticsImport";a.type="text/javascript";var c="";void 0!==b&&void 0!==b.oid&&(c=b.oid);a.setAttribute("data-oid",c);a.src="https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js";a.addEventListener("load",function(d){for(olytics.initialize({Olytics:b});0<window.a.length;){d=window.a.shift();var e=d.shift();olytics[e]&&olytics[e].apply(olytics,d)}},
|
|||
|
|
!1);c=document.getElementsByTagName("script")[0];c.parentNode.insertBefore(a,c)}};olytics.load({oid:window.oid});
|
|||
|
|
//]]>
|
|||
|
|
</script>
|
|||
|
|
<script type="text/javascript" id="">
|
|||
|
|
//<![CDATA[
|
|||
|
|
if(window.olytics){var qtxSection="0"!=google_tag_manager["GTM-KLQFWCZ"].macro(5)?google_tag_manager["GTM-KLQFWCZ"].macro(6):"HomePage";window.olytics.fire({behaviorId:window.bid,category:google_tag_manager["GTM-KLQFWCZ"].macro(7),tag:google_tag_manager["GTM-KLQFWCZ"].macro(8)})};
|
|||
|
|
//]]>
|
|||
|
|
</script>
|
|||
|
|
<link rel="stylesheet" href="https://olytics.omeda.com/olytics/css/v3/p/olytics.css" />
|
|||
|
|
<script type="text/javascript" id="">
|
|||
|
|
//<![CDATA[
|
|||
|
|
(function(b,a,c){var e=decodeURIComponent;var d="||";var g=";;",f="split",h="length",m="indexOf",k="localStorage",l="_ccmdt";b[c]=b[c]||{};b[c].us={};a=b[k]?b[k][l]||"":(a=a.cookie.match(l+"\x3d([^;]*)"))&&a[1]||"";e=e(a)[f](d);a=e[h];if(0<a)for(;a--;)d=e[a][f]("\x3d"),1<d[h]&&(-1<d[1][m](g)?(b[c].us[d[0]]=d[1][f](g),b[c].us[d[0]].pop()):b[c].us[d[0]]=d[1])})(window,document,"_ml");
|
|||
|
|
(function(){_ml=window._ml||{};_ml.eid="66459";_ml.fp="undefined";_ml.ef=["#Email"];_ml.informer={callback:function(a,b){"undefined"==typeof dataLayer||_ml.isEmptyObj(_ml.us)||dataLayer.push({event:"Bombora_Informer",Bombora_Topic:_ml.us.tp&&0<_ml.us.tp.length?_ml.us.tp[0]:"",Bombora_Company_Revenue:_ml.us.cr,Bombora_Company_Size:_ml.us.cs,Bombora_Domain:_ml.us.dm,Bombora_Seniority:_ml.us.sn,Bombora_Predictive_Category:_ml.us.pc&&0<_ml.us.pc.length?_ml.us.pc[0]:"",Bombora_Decision_Maker:_ml.us.dcm,
|
|||
|
|
Bombora_Functional_Area:_ml.us.fa&&0<_ml.us.fa.length?_ml.us.fa[0]:"",Bombora_Install_Data:_ml.us.ins&&0<_ml.us.ins.length?_ml.us.ins[0]:"",Bombora_Professional_Group:_ml.us.pg&&0<_ml.us.pg.length?_ml.us.pg[0]:"",Bombora_Education:_ml.us.edu,Bombora_Industry:_ml.us.ind})},enable:!0};var b=document.getElementsByTagName("script")[0],a=new Date,c=document.createElement("script");c.type="text/javascript";c.async=!0;c.src="https://ml314.com/tag.aspx?"+a.getDate()+a.getMonth()+a.getFullYear();b.parentNode.insertBefore(c,
|
|||
|
|
b)})();
|
|||
|
|
//]]>
|
|||
|
|
</script>
|
|||
|
|
<script src="https://player.hbmp.mediafuse.com/prebidlink/458804/hbw_master_302826_6936.js" async="async"></script><iframe src="https://p.deliveryapis.com/prebidlink/19116/j.html?i=11597" style="display: none;"></iframe>
|
|||
|
|
<script async="async" src="https://sync.medidexs.com/ps/10/7c3.js"></script>
|
|||
|
|
<script async="async" src="https://a.ad.gt/api/v1/u/matches/170"></script>
|
|||
|
|
<script async="async" src="https://api.fouanalytics.com/api/init-1016mnvd6jvjr44ajs9g.js"></script><iframe src="https://25e5d56134a6a8adeb5a76b0eb7e9f16.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html" style="visibility: hidden; display: none;"></iframe><img alt="" style="display:none;width:1px;" src="https://idsync.rlcdn.com/423396.gif?partner_uid=4181968444665057810" /><img height="1" width="1" src="https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=AU1D-0100-001651697744-CIIGXHMK-F4XV&adnxs_id=$UID" alt="" style="display: none;" /><img height="1" width="1" src="https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=AU1D-0100-001651697744-CIIGXHMK-F4XV" alt="" style="display: none;" /><img height="1" width="1" src="https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3DAU1D-0100-001651697744-CIIGXHMK-F4XV" alt="" style="display: none;" /><img height="1" width="1" src="https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=AU1D-0100-001651697744-CIIGXHMK-F4XV" alt="" style="display: none;" /><img height="1" width="1" src="https://ids.ad.gt/api/v1/g_hosted?id=AU1D-0100-001651697744-CIIGXHMK-F4XV" alt="" style="display: none;" /><img height="1" width="1" src="https://token.rubiconproject.com/token?pid=50242&puid=AU1D-0100-001651697744-CIIGXHMK-F4XV&gdpr=0" alt="" style="display: none;" /><img height="1" width="1" src="https://match.prod.bidr.io/cookie-sync/audigent?buyer_user_id=AU1D-0100-001651697744-CIIGXHMK-F4XV" alt="" style="display: none;" /><img height="1" width="1" src="https://sync.mathtag.com/sync/img?redir=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fmediamath_match%3Fuser_id%3D%5BMM_UUID%5D%26id%3DAU1D-0100-001651697744-CIIGXHMK-F4XV" alt="" style="display: none;" /><img height="1" width="1" src="https://sync.go.sonobi.com/us?https://ids.ad.gt/api/v1/son_match?id=AU1D-0100-001651697744-CIIGXHMK-F4XV&uid=[UID]" alt="" style="display: none;" /><img height="1" width="1" src="https://trc.taboola.com/sg/audigent/1/cm?redirect=http%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Ftaboola%3Fpartner_uid%3D%3CTUID%3E%3Fid%3DAU1D-0100-001651697744-CIIGXHMK-F4XV" alt="" style="display: none;" />
|
|||
|
|
<div style="position: absolute; margin: 0px; padding: 0px; border: 0px; height: 0px; width: 0px; overflow: hidden;">
|
|||
|
|
<span style="font: 999px "Nimbus Sans", monospace;">ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789-_~</span><a aria-hidden="true"></a><button aria-hidden="true">x</button><input aria-hidden="true" />
|
|||
|
|
</div>
|
|||
|
|
<script type="text/javascript" src="https://pixels.ad.gt/api/v1/getpixels?tagger_id=e0fc5aa47bed062e265fc29d169e5770&url=https%3A%2F%2Fwww.fiercepharma.com%2Fmarketing%2Fnovavax-eyeing-covid-vaccine-hesitant-and-kids-unveils-new-education-campaigns-nuvaxovid&code='none'" async="async"></script><img alt="" style="display:none;width:1px;" src="https://ib.adnxs.com/seg?member=827&add=29315642,29315652,29028703,16013439,16671093" /><iframe src="https://gum.criteo.com/syncframe?origin=publishertag&topUrl=www.fiercepharma.com#{"uid":{"origin":0},"lwid":{"origin":0},"bundle":{"value":"8SLAY19jc04wYVc4U3FGV1lvQ2RnMkZ2MURmM2F2TCUyRk9QWDhwRGRDUDdncjFRajVyVktzZTMlMkZlUkJJViUyRjRUbEJjZEVlZmptbkpwSkxSMkNtOHFFblZLNSUyQnZlQThTd1liZGh1QVdubTg4cENXM0N4VTYlMkJqUU1KS3FnQXN0MG92eEhoTDlrZ3JTamhuYWNNT21tWkNwN0xBSk1RJTNEJTNE","origin":3},"optout":{"value":false,"origin":0},"sid":{"origin":0},"ifa":{"origin":0},"tld":"fiercepharma.com","topUrl":"www.fiercepharma.com","version":117,"cw":true,"lsw":true,"origin":"publishertag"}" id="criteo-syncframe-pbt" width="0" height="0" frameborder="0" title="Criteo GUM iframe" style="border-width: 0px; margin: 0px; display: none;" name="criteo-syncframe-pbt"></iframe>
|
|||
|
|
<script type="text/javascript" src="https://tpc.googlesyndication.com/sodar/sodar2.js"></script>
|
|||
|
|
</body>
|
|||
|
|
</html>
|